10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT UNDER SECTION 13 0R 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the quarterly period ended: March 31, 2013

¨ TRANSITION REPORT UNDER SECTION 13 0R 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from:

Commission file number: 002-95626-D

SIONIX CORPORATION

(Exact name of registrant as specified in its charter)

Nevada	87-0428526
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.
2010 N Loop Freeway W, Suite 110 Houston, Texas	77018
(Address of principal executive offices)	(Zip Code)

Issuer’s telephone number (713) 682-6500

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period than the registrant was required to submit and post such files).  Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filed,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨	Accelerated filer ¨
Non-accelerated filer ¨ (Do not check if a smaller reporting company)	Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ¨ Yes x No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.  As of May 1, 2013 the number of shares of the registrant’s classes of common stock outstanding was 454,866,623.

Table of Contents

Part I - Financial Information	3
Item 1. Condensed Consolidated Financial Statements (Unaudited)	3
(Unaudited ) Balance Sheets as of March 31, 2013 and September 30, 2012	3
(Unaudited) Statements of Operations for the three and six months ended March 31, 2013 and 2012	4
(Unaudited ) Statements of Cash Flows for the six months ended March 31, 2013 and 2012	5
Notes to financial statements	6
Forward-Looking Statements	14
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	14
Item 3. Quantitative and Qualitative Disclosures About Market Risk	18
Item 4. Controls and Procedures	18
Part II – Other Information	18
Item 1. Legal Proceedings	18
Item 1A. Risk Factors	18
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	18
Item 3. Defaults Upon Senior Securities	19
Item 4. Mine Safety Disclosure	19
Item 5. Other Information	19
Item 6. Exhibits	19
Signatures	20

2 

Part I, Item 1.  Financial Statements.

Sionix Corporation

Condensed Consolidated Balance Sheets

(Unaudited)

	As of March 31, 2013			As of  September 30, 2012
ASSETS
Current assets:
Cash and cash equivalents	$	27,235		$	1,348,069
Other receivable		12,500			27,854
Inventory		790,000			1,311,349
Other current assets		116,423			91,529
Total current assets		946,158			2,778,801
Non-current assets:
Property and equipment, net		70,792			128,119
Total assets	$	1,016,950		$	2,906,920
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable	$	263,306		$	155,547
Accrued Expenses		1,294,468			907,728
Notes payable - related parties		45,000			25,000
Convertible notes, net of debt discount		2,005,146			1,895,378
Secured promissory notes		64,027			64,027
Deferred Revenue		10,000			10,000
Derivative liability		4,478,105			638,178
Shares to be issued		-			165,880
Total current liabilities		8,160,052			3,628,699
Long-Term Debt, net of discount		793,355			-
Total Liabilities	$	8,953,407		$	4,023,392
Stockholders' Deficit
Stockholders' Deficit Attributable to Sionix Corporation:
Preferred stock, $0.001 par value, 10,000,000 shares authorized at March 31, 2013		-			-
Common stock, $0.001 par value (600,000,000 shares authorized; 451,246,460 shares issued and outstanding at March 31, 2013; 387,968,434 shares issued and outstanding at September 30, 2012)		451,246			387,968
Additional paid-in capital		36,089,172			34,807,672
Accumulated deficit		(44,476,875	)		(37,560,000	)
Total stockholders' deficit attributable to Sionix Corporation		(7,936,457	)		(2,364,360	)
Equity attributable to noncontrolling interest		-			1,247,888
Total stockholders' deficit		(7,936,457	)		(1,116,472	)
Total liabilities and stockholders' deficit	$	1,016,950		$	2,906,920

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

Sionix Corporation

Condensed Consolidated Statements of Operations

(Unaudited)

	Three Months Ended March 31,						Six Months Ended March 31,
	2013			2012			2013			2012
Net Revenue		27,500			-			27,500			-
Cost of revenues		4,558			-			4,558			-
Gross profit		22,942			-			22,942			-
Operating expenses
General and administrative		790,506			587,167			1,293,370			1,372,788
Sales and marketing		6,096			62,882			53,812			148,307
Research and development		856,544			171,581			1,137,388			314,873
Depreciation		7,309			3,942			17,377			7,448
Total operating expenses		1,660,455			825,572			2,501,948			1,843,416
Loss from operations		(1,637,513	)		(825,572	)		(2,479,006	)		(1,843,416	)
Other income (expense)
Interest expense and financing costs		(204,480	)		(243,731	)		(500,890	)		(462,625	)
Loss on change in fair value of derivative liability		(4,185,376	)		(1,698	)		(4,107,185	)		(1,373	)
Other income		(2,301	)		-			(4,528	)		-
Legal settlements		-			-			-			-
Gain (Loss) on settlement of debt		170,703			(238,804	)		174,734			(196,893	)
Total other income (expense)		(4,221,545	)		(484,233	)		(4,437,870	)		(660,891	)
Loss before income taxes		(5,858,967	)		(1,309,805	)		(6,916,876	)		(2,504,307	)
Income taxes		-			-			-			-
Net loss		(5,858,967	)		(1,309,805	)		(6,916,876	)		(2,504,307	)
Less: Net loss attributable to the noncontrolling interest		-			2,587			-			2,587
Net loss attributable to Sionix Corporation	$	(5,858,967	)	$	(1,307,2180	)	$	(6,916,876	)	$	(2,501,720	)
Amounts attributable to Sionix Corporation:
Basic loss per share	$	(0.01	)	$	(0.00	)	$	(0.02	)	$	(0.01	)
Diluted loss per share	$	(0.001	)	$	(0.00	)	$	(0.02	)	$	(0.01	)
Basic weighted average number of shares of common stock outstanding		440,415,881			324,493,782			419,966,351			314,627,551
Diluted weighted average number of shares of common stock outstanding		440,415,881			324,493,782			419,966,351			314,627,551

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

Sionix Corporation

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Six Months Ended March 31,
	2013			2012
Cash flows from operating activities
Net loss	$	(6,916,876	)	$	(2,504,307	)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation		17,377			7,448
Amortization of debt discounts		412,405			222,569
Share based payments		14,671			139,420
Common stock issued for services		215,078			729,551
(Gain) loss on change in fair value of derivative liability		4,107,185			1,373
Loss on sale of property and equipment		4,528			-
(Gain) loss on settlement of debt		(174,734	)		196,893
Changes in operating assets and liabilities:
Inventory		521,349			(48,279	)
Other current assets		(91,618	)		(212,255	)
Accounts payable		20,178			(10,696	)
Accrued expenses		418,653			415,052
Deferred revenue		-			-
Net cash used by operating activities		(1,451,802	)		(1,063,231	)
Cash flows from investing activities:
Proceeds from sale of property and equipment, net		5,748			(41,192	)
Cash flows from financing activities:
Borrowings, net		665,193			592,500
Common stock issued for cash		-			400,200
Noncontrolling interests in subsidiary issued for cash		(569,647	)		1,350,000
Net cash provided by financing activities		95,546			2,342,700
Net increase (decrease) in cash and cash equivalents		(1,320,834	)		1,238,277
Cash and cash equivalents, beginning of period		1,348,069			685
Cash and cash equivalents, end of period	$	27,235		$	1,238,962
SUPPLEMENTARY CASH FLOW INFORMATION:
Income taxes paid	$	-		$	599
Interest paid	$	-		$	-
Common stock issued in redemption of subsidiary interests	$	450,000		$

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

Sionix Corporation

Notes to Condensed Consolidated Unaudited Financial Statements

Note 1 – Organization and Description of Business

Sionix Corporation (the "Company") was incorporated in Utah in 1996.  The Company completed its reincorporation as a Nevada corporation effective July 1, 2003. Sionix designs, develops, markets and sells cost-effective water management and treatment solutions intended for use in the oil and gas, agriculture, food processing, industrial, disaster relief, and municipal (both potable and wastewater) markets  The Company’s water treatment systems include filtration, pretreatment, pH control, clarification, ultra violet, reverse osmosis and feature the patented Sionix Dissolved Air Flotation (“DAF”) technology.  The proprietary DAF system incorporates unique design elements including a distribution of fine, small diameter air bubbles that remove most solid particles, hydrocarbons and dissolved gases from the influent.  The micro-bubbles capture contaminants and float them to the surface of the DAF tank where they are skimmed off.

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies

In the opinion of management, the accompanying balance sheets and related interim statements of operations, and cash flows include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s annual report on Form 10-K for the fiscal year ended September 30, 2012 filed with the U.S. Securities and Exchange Commission (the “Commission”) on December 31, 2012.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  Significant estimates include collectability of accounts receivable, accounts payable, sales returns, and recoverability of long-term assets.

Consolidation

All significant intercompany accounts and balances have been eliminated in consolidation. Participation of other unit holders in the net assets and net earnings of consolidated subsidiaries is included in the captions ‘equity attributable to noncontrolling interest’ and ‘net loss attributable to the noncontrolling interest’ in the accompanying condensed consolidated balance sheet and condensed consolidated statement of operations, respectively.

Recently Issued Accounting Pronouncements

In December 2011, the FASB issued disclosure guidance related to the offsetting of assets and liabilities. The guidance requires an entity to disclose information about offsetting and related arrangements for recognized financial and derivative instruments to enable users of its financial statements to understand the effect of those arrangements on its financial position. The amended guidance is effective for us on a retrospective basis commencing in the first quarter of 2014. We are currently evaluating the impact of this new guidance on our consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, “Intangibles – Goodwill and Other (Topic 350): Testing Goodwill for Impairment.” ASU No. 2011-08 provides companies an option to perform a qualitative assessment to determine whether further goodwill impairment testing is necessary. If, as a result of the qualitative assessment, it is determined that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, the two-step quantitative impairment test is required. Otherwise, no further testing is required. ASU No. 2011-08 will be effective for the Company for goodwill impairment tests performed in the fiscal year ending September 30, 2013, with early adoption permitted. The adoption of this guidance is expected to have no impact on the Company’s consolidated financial condition and results of operations.

6

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220): Presentation of Comprehensive Income.” ASU No. 2011-05 eliminates the option to present components of other comprehensive income as part of the statement of shareholders’ equity. All non-owner changes in shareholders’ equity instead must be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Also, reclassification adjustments for items that are reclassified from other comprehensive income to net income must be presented on the face of the financial statements. ASU No. 2011-05 was effective for the Company for the quarter ending December 31, 2012. The adoption of this guidance had no impact on the Company’s financial condition and results of operations.

In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs.” ASU No. 2011-04 clarifies and changes the application of various fair value measurement principles and disclosure requirements, and was effective for the Company in the second quarter of fiscal 2012 (January 1, 2012). The adoption of this guidance had no impact on the Company’s consolidated financial condition and results of operations.

Note 3 – Property and Equipment

Property and equipment consisted of the following at:

	March 31, 2013			September 30, 2012
Machinery and equipment	$	109,336		$	166,159
Less accumulated depreciation		(38,544	)		(38,040	)
Property and equipment, net	$	70,792		$	128,119

Depreciation expense for the three months ended March 31, 2013 and 2012 was $7,309 and $3,942, respectively. For the six months ended March 31, 2013 and 2012, depreciation expense was $17,377 and $7,448, respectively.

Note 4 – Accrued Expenses

Accrued expenses consisted of the following at:

	March 31, 2013		September 30, 2012
Accrued salaries	$	412,938	$	306,055
Interest payable		464,457		364,567
Other accrued expenses		417,073		237,106
Total accrued expenses	$	1,294,468	$	907,728

During the three months ended March 31, 2012, $13,032 of accrued interest was included in the conversion of notes payable into common stock described in Note 6.

Note 5 – Notes Payable – Related Parties

The Company has received advances in the form of unsecured promissory notes from stockholders. The original date of these advances was November 2009, March 2011, October 2011 and March 2013. These notes bear interest at rates up to 10% and are due on demand. As of March 31, 2013 and December 31, 2012, such notes payable amounted to $45,000 and $25,000, respectively. Accrued interest on the notes amounted to $21,081 and $20,356 at March 31, 2013 and December 31, 2012, respectively, and is included in accrued expenses. Interest expense on these notes for the three months ended March 31, 2013 and 2012 amounted to $725 and $639, respectively. No demand for payment has been made as of March 31, 2013.

7

Note 6 – Convertible Notes

At March 31, 2013 and December 31, 2012, convertible notes payable amounted to $2,231,849 and $1,983,358, respectively, net of discounts of $202,789 and $355,680 respectively. The notes bear interest at 6% - 12% per annum, and are convertible into common stock of the Company at $0.02 - $0.15 per share (as well as variable conversion rates as described below). The notes are due at various dates through September 2014 and are unsecured.

Unsecured Convertible Notes:

Through December 31, 2012, the Company issued $700,000 of convertible debentures (of which $87,500 is outstanding at December 31, 2012) that are convertible into common stock of the Company at variable conversion rates that provide a fixed rate of return to the note-holder. Under the terms of the notes, however, the Company could be required to issue additional shares of common stock in the event of default. The Company applied the provisions of ASC Topic 815, “Derivatives and Hedging” and determined that the conversion option should be bifurcated from the notes and valued separately. This conversion option has been recorded as a derivative liability, is being amortized over the terms of the related notes, and is carried at fair value in the accompanying balance sheet. During the three months ended December 31, 2012 and 2011, the change in fair value of this derivative liability amounted to $78,191 and $325, respectively.

During the three months ended December 31, 2012, holders of convertible debentures elected to convert $82,500 of their debt plus accrued interest into 8,569,317 shares of common stock.

6% Convertible Redeemable Note:

On November 23, 2011 Sionix issued a 6% Convertible Redeemable Note in the principal amount $100,000 maturing on November 23, 2012. In addition, the Company received a commitment in the form of a promissory note from the lender pursuant to which the lender provided the Company with funding of up to an additional $300,000 beginning on June 1, 2012, at which time $100,000 became available, on each of June 1, 2012, July 1, 2012 and August 1, 2012 (the "Additional Financing"). All funds were advanced as agreed for a total of $400,000. Sionix paid fees of $45,000 in connection with the funding of these loans. The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.

For the period ending December 31, 2012 there was $36,600 outstanding on these Notes.

On September 21, 2012 Sionix issued a 6% Convertible Redeemable Note in the principal amount $100,000 to GEL Properties.  The note matures on September 21, 2013.  The Company has an optional right of redemption prior to maturity upon a five-day notice and payment of a 50% premium on the unpaid principal amount of the loan.  The Company paid fees of $6,000 in connection with the funding of this loan. In addition, the Company received a commitment in the form of a promissory note from GEL Properties pursuant to which it will provide Sionix with funding of an additional $300,000, $100,000 of which will become available on each of July 1, 2013, August 15, 2013 and October 1, 2013.  The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.

For the period ending December 31, 2012 there was $100,000 outstanding on these Notes.

10% Convertible Debentures:

On September 29, 2012 the Company entered into a securities purchase agreement dated September 25, 2012 with several accredited investors (“Holders”) for the purchase and sale of $1,025,000 of its convertible notes (“Notes”) and warrants.    The Notes bear interest at the rate of 10% per annum beginning as of September 25, 2012, and mature on June 25, 2013.  On the closing date, the Company paid and the Holders received nine months of pre-paid interest on the original principal amount of the Notes (based on the agreed nine-month term of the Notes).

The Notes are convertible at any time at the option of the Holders into the Company’s common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request, however the conversion price may not exceed $0.04, and may not be lower than $0.02 per share.  The Notes may be redeemed by the Company at any time prior to maturity with ten days’ prior notice to the Holders, and payment of a premium of 25% on the unpaid principal amount of the Notes.  In addition the Notes and related securities purchase agreement contain representations, warranties and covenants that are customary for financings of this type.

8

The Company issued warrants to the Holders for the purchase of up to 23,125,000 shares of Company common stock, pro rata in proportion to the amount invested, which can be exercised for a period of five years from the closing date, with a fixed exercise price of $0.08 per share.

The Company agreed to register the common stock into which the Notes may be converted, any shares of common stock that may be issued as payment of principal or interest, and the common stock underlying the warrants, as well as any shares of common stock that may be issued as a result of any stock split, dividend or other distribution. The Company agreed to file an initial registration statement within 30 days of the date of the registration rights agreement.  If the Company fails to file a registration statement within this 30 day period, or to have it declared effective within 90 days after the date of the registration rights agreement, or to maintain its effectiveness (in addition to other events described in the full text of the registration rights agreement), the Company will be obligated to pay the investors liquidated damages equal to 2% of the principal amount of the Notes per month until the event is cured, for up to one year, and 1% per month thereafter if the event continues uncured

The offering was made with the services of a placement agent.  At the closing of the sale and issuance of the Notes, the Company paid a cash fee to the placement agent in the amount of $87,535 or 8.54% of the gross proceeds of the offering.

January Convertible Notes:

On January 25, 2013 the Company entered into securities purchase agreements (the “January SPAs”) with two (2) accredited investors (the “January Holders”) for the purchase and sale of $140,000 of convertible notes (the “January 2013 Notes”) convertible into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a conversion price equal to 80% of the average of the three (3) lowest closing prices for the Common Stock during the ten (10) consecutive trading days immediately preceding the conversion request, however the conversion price may not exceed $0.04 and may not be lower than $0.02 per share.   The January 2013 Notes bear interest at the rate of 10% per annum and mature on September 30, 2014.  The January 2013 Notes are convertible at any time at the option of the January Holders (subject to an increase in the Company’s authorized Common Stock, or a reverse split of its existing outstanding Common Stock with no change to its authorized Common Stock).  The Company may redeem the January 2013 Notes at any time prior to maturity with twenty (20) days’ prior notice to the January Holders and payment of a premium of 20% on the unpaid principal amount. 

In addition, the January 2013 Notes and January SPAs provide the January Holders with registration rights for the shares of Common Stock underlying the January 2013 Notes. If the Company fails to file a registration statement with the SEC covering such shares within thirty (30) days from the date of the January Notes, the Company shall pay to the January Holders an amount in cash, as partial liquidated damages, equal to 2% of the aggregate purchase price paid by the January Holders pursuant to the January SPAs until the first anniversary of the issue date and 1% of the same per month thereafter, not to exceed 10% of the principal amount in the aggregate.

March Convertible Notes:

On March 13, 2013 the Company entered into securities purchase agreements  (the “March SPAs”) with five (5) accredited investors (the “March Holders”) for the purchase and sale of $60,000 of convertible notes (the “March 2013 Notes”) convertible into shares of the Company’s Common Stock at a fixed conversion price of $0.02 per share.   The March 2013 Notes bear interest at the rate of 10% per annum and mature on September 30, 2014.  The March 2013 Notes are convertible at any time at the option of the March Holders (subject to an increase in the Company’s authorized Common Stock, or a reverse split of its existing outstanding Common Stock with no change to its authorized Common Stock).  The Company may redeem the March 2013 Notes at any time prior to maturity with twenty (20) days’ prior notice to the March Holders and payment of a premium of 20% on the unpaid principal amount.

Note 7 – 12% Secured Promissory Note

On November 8, 2011 Sionix issued a 12% Secured Promissory Note in the principal amount of $300,000 maturing on July 31, 2012. The Company had an optional right of redemption prior to maturity. Sionix was to redeem the debenture on the maturity date at a redemption premium of 7.5%. Sionix granted to the investor a continuing, first priority security interest in certain property of Sionix to secure the prompt payment, performance, and discharge in full of all of the Company’s obligations under the Secured Promissory Note, Securities Purchase Agreement, and Pledge Agreement.

9

In connection with this borrowing, Sionix issued 2,358,491 shares of common stock as Incentive Shares, and 16,981,132 shares of common stock as Pledged Shares. At the Company’s option, the Incentive Shares may be redeemed for cash in the amount of $125,000; otherwise they are retained by the lender. The value of the Incentive Shares has been classified as a liability and is being amortized as interest expense over the term of the borrowing. The Pledged Shares were issued as security under the Pledge Agreement.

The Company is continuing to issue shares to reduce the outstanding balance, and no default based on the elapsed maturity date has been declared by the note holder.  After conversions, the amount outstanding as of December 31, 2012 amounted to $64,027.

Note 8 – Long Term Debt

10% Convertible Debt (WBI):

On November 26, 2012 Sionix completed the repurchase of all outstanding membership interests in WBI.  In return for their membership interests and the release of WBI from any future claims, the Company offered the members the option of receiving a pro-rata share of the remaining capital invested into WBI, or they could assign their rights to their remaining capital to Sionix in return for a convertible note issued by Sionix equal to 100% of their original investment. The pro-rata share calculation did not include Sionix's interest in WBI. The cash available for distribution totaled $854,046 or 63.3% of the original investment of $1,350,000. The Company returned $569,649 of the original capital invested, representing an original investment of $900,000.

The Company issued convertible notes in the amount of $450,000 and received $284,397 of the remaining capital.  In addition, the Company received $250,000 of new capital in return for the issuance of an additional note of $394,000, and recognized a debt discount of $144,000 in connection with this new note.

The convertible notes issued mature on September 30, 2014, bear an annual interest rate of 10% payable in cash or in kind at our election, and are convertible at the election of the holder into common shares of Sionix at a rate of $0.04.

As part of this offering, the Company paid a placement agent a fee of $45,000 for services rendered in connection with this transaction.

Note 9 – Income Taxes

For the six months ended March 31, 2013, the accompanying Condensed Consolidated Statements of Operations reflect net income that is largely comprised of items that do not represent taxable income.

Note 10 – Stockholders’ Equity

Common Stock

The Company has 600,000,000 authorized shares of common stock, par value $0.001 per share. As of March 31, 2013, the Company had 451,246,460 shares issued and outstanding. As of September 30, 2012, the Company had 387,968,434 shares of common stock issued and outstanding.

During the six months ended March 31, 2013, the Company issued 7,314,379 shares of common stock for services to officers, directors and consultants (valued at $215,078) based on closing market prices. The Company also issued 40,220,361 shares of common stock for conversion of debt in the amount of $712,837 (including interest).

10

Employee Stock Options and Warrants

Stock Options

A summary of the Company’s activity for employee stock options and warrants:

	Number of Options			Weighted  Average  Exercise Price		Aggregate Intrinsic Value		Weighted  Average  Remaining  Contractual Life
Outstanding at October 1, 2012		43,716,316		$	0.12	$	-		3.01
Granted		500,000			0.15		-		4.75
Expired		(3,933,526	)		0.21		-		-
Forfeited		(500,000	)		0.15		-		-
Exercised		-			-		-		-
Outstanding at March 31, 2013		39,782,790			0.11		-		1.98
Exercisable at March 31, 2013		39,779,665		$	0.11	$	-		1.98

Outstanding and exercisable as of March 31, 2013:

	Exercise Price	Options Outstanding		Contractual Life		Weighted Average Remaining Options Exercisable		Weighted Average Remaining Contractual Life
$	0.06		7,415,000		2.44		7,411,875		2.44
$	0.07		2,000,000		2.75		2,000,000		2.75
$	0.09		2,000,000		2.75		2,000,000		2.75
$	0.10		8,416,850		1.51		8,416,850		1.51
$	0.12		8,450,940		1.03		8,450,940		1.03
$	0.14		500,000		3.17		500,000		3.17
$	0.15		11,000,000		2.16		11,000,000		2.16
			39,782,790		1.98		39,779,665		1.98

During the six months ended March 31, 2013, the Company granted a total of 500,000 options and warrants to certain officers and employees. The options and warrants vested immediately upon grant and have a term of five years. The weighted average grant-date fair value of these options and warrants was $14,671.  The fair value of these options and warrants was estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

● risk free rate of return of 0.72%;

● volatility of 171%

● dividend yield of 0%; and

● expected term of 5 years.

Stock Warrants

A summary of the Company’s warrant activity with non-employees:

	Number of Warrants			Weighted  Average  Exercise Price		Aggregate Intrinsic Value
Outstanding at October 1, 2012		114,460,085		$	0.12	$	75,000
Granted		625,000			-		-
Expired		(4,223,182	)		0.18		-
Forfeited		-			-		-
Exercised		-			-		-
Outstanding as of March 31, 2013		110,011,903		$	0.11	$	75,000
Exercisable as of March 31, 2013		110,011,903		$	0.11	$	75,000

11

Warrants outstanding and exercisable as of March 31, 2013:

						Weighted
						Average
						Remaining		Weighted Average
	Exercise	Warrants		Warrants		Contractual		Exercise Price
	Price	Outstanding		Exercisable		Life		Outstanding		Exercisable
$	0.06		11,262,500		11,262,500		3.17	$	0.06	$	0.06
$	0.07		22,833,333		22,833,333		1.04	$	0.07	$	0.07
$	0.08		25,425,000		25,425,000		4.12	$	0.08	$	0.08
$	0.10		6,726,578		6,726,578		2	$	0.10	$	0.10
$	0.12		6,226,000		6,226,000		.69	$	0.12	$	0.12
$	0.14		5,000,000		5,000,000		2.56	$	0.14	$	0.14
$	0.15		2,107,667		2,107,667		1.58	$	0.15	$	0.15
$	0.17		24,230,825		24,230,825		2.61	$	0.17	$	0.17
$	0.25		3,700,000		3,700,000		.82	$	0.25	$	0.25
$	0.30		2,500,000		2,500,000		.33	$	0.30	$	0.30
			110,011,903		110,011,903

Warrants expiring within twelve months of March 31, 2013 total 28,531,856.

Note 11 – Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of the Company’s assets and the satisfaction of its liabilities in the normal course of business. Through March 31, 2013, the Company has incurred cumulative losses of $44,476,875, including a net loss for the six months ended March 31, 2012 of $6,916,876. As the Company has limited cash flow from operations, its ability to maintain normal operations is entirely dependent upon obtaining adequate cash to finance its overhead, research and development activities, and acquisition of production equipment. It is unknown when, if ever, the Company will achieve a level of revenues adequate to support its costs and expenses. In order for the Company to meet its basic financial obligations, including salaries, debt service and normal operating expenses, it plans to sell additional units of its water treatment systems, and to seek additional equity or debt financing. Because of the Company’s history and current debt levels, there is considerable doubt that the Company will be able to obtain financing. The Company’s ability to meet its cash requirements for the next twelve months depends on its ability to obtain such financing. Even if financing is obtained, any such financing will likely involve additional fees and debt service requirements which may significantly reduce the amount of cash we will have for our operations. Accordingly, there is no assurance that the Company will be able to implement its plans.

As mentioned in Notes 5, 6, 7 and 8, the Company has related party notes, convertible notes, and subordinated debentures that have matured. The Company is continuing its efforts to obtain customers for its products expand its sales efforts worldwide and expand the industries it targets for possible customers. The Company also has future plans for additional products, and revisions to its current products. In support of this the Company plans to hire additional personnel who have the industry experience and the training so that they can be immediately effective in the building of the Company. The Company has dedicated significant resources to apply its technology to the treatment of both production and flow back water from oil and gas fracking operations.  Field and laboratory tests were conducted in the Bakken Shale area of North Dakota and the Company will continue to develop commercial opportunities to treat both production and flow back water for reuse in fracking as a strategic market objective.  The Company is also continuing to seek additional investment capital in the form of debt or equity to continue operations, and is considering certain changes to its capital structure to become more attractive to potential investors and business partners.

Note 12 – Subsequent Events

Additional 10% Convertible Debentures:

Subsequent to the period ended March 31, 2013 the Company received additional funding of $150,000 in principal amount of 10% Convertible Promissory Notes which have not yet been converted into shares of our common stock.  The notes are convertible at any time at the option of the holders into shares of our common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request, however the conversion price may not exceed $0.04, and may not be lower than $0.02 per share.  Based on the outstanding principal amount of these notes and assuming that interest accrued through December 31, 2014, the due date, the notes would be convertible into approximately 7,000,000 shares of our common stock at a conversion price of $0.02 a share.

12

Additional 6% Convertible Redeemable Note:

Subsequent to the period ended March 31, 2013 the Company received an advance of $50,000 in principal amount based on the 6% Convertible Redeemable Note agreement.

JMJ Financial Convertible Promissory Note

On April 11, 2013 (the “JMJ Effective Date”), the Company issued a Convertible Promissory Note to JMJ Financial (the “JMJ Note”) in the principal amount of $75,000 (the “JMJ Principal Amount”), including a 10% original issue discount, at a conversion price equal to 60% of the three (3) lowest closing price of the Company’s common stock for a period of twenty (20) trading days, but no lower than $0.03 per share.  The JMJ Note matures on April 11, 2014. The Company has an optional right of redemption at any time before ninety (90) days from the JMJ Effective Date, after which prepayment may not be made without prior approval from the lender and a one-time interest charge of 12% will be applied to the JMJ Principal Amount. The JMJ Note also provides for up to an additional $175,000 to be provided to the Company at the lender’s sole discretion.

The shares underlying conversion of the JMJ Note have piggyback registration rights and if the Company fails to register such shares in its next registration statement filed with the SEC a liquidated damage charge of 25% of the outstanding principal balance, but not less than $25,000, shall be added to such outstanding balance.

Tonaquint Convertible Promissory Note

On April 19, 2013, pursuant to the terms and conditions of that certain securities purchase agreement, by and between the Company and Tonaquint, Inc. (“Tonaquint), the Company issued to Tonaquint: i) a convertible promissory note (the “Tonaquint Note”) in the principal amount of $155,000 (the “Tonaquint Principal Amount”), including a 10% original issue discount, maturing on August 19, 2014 (the “Maturity Date”) and ii) a five (5) year warrant (the “Tonaquint Warrant”) to purchase that number of shares of the Company’s Common Stock equal to $62,000, convertible at a conversion price as set forth in the Tonaquint Note and exercisable at $0.06 per share, as adjusted pursuant to the terms and conditions of the Tonaquint Warrant. The Company paid fees of $5,000 incurred by Tonaquint in connection with the funding of this loan. The Company has the optional right to prepay any portion of the Tonaquint Principal Amount upon providing Tonaquint with five (5) days’ notice of such prepayment, provided that the Company must pay Tonaquint 135% of the amount of the Tonaquint Principal Amount it elects to prepay. Interest on the Tonaquint Note shall accrue at 8% per annum, provided that upon an Event of Default (as defined in the Tonaquint Note) the interest rate shall increase to 18%.

The conversion price for each share of Common Stock issuable pursuant to the Tonaquint Note and the Tonaquint Warrant will be $0.03 (the “Conversion Price”), subject to adjustments as set forth in the Tonaquint Note and the Tonaquint Warrant; provided, however, that, beginning on a date that is 180 days after the date of issuance of the Tonaquint Note, the Company shall pay, on a monthly basis, the greater of (i) $15,500, plus the sum of any accrued and unpaid interest as of the applicable installment date and accrued, and unpaid late charges, if any, under the Tonaquint Note as of the applicable installment date, and any other amounts accruing or owing to Tonaquint and (ii) the then outstanding balance of the Tonaquint Note divided by the number of installment dates remaining prior to the Maturity Date (each, an “Installment Amount’). Notwithstanding any other provision of the Tonaquint Note, if any Installment Amount is greater than the then outstanding balance of the Tonaquint Note, such Installment Amount shall be reduced to equal such then outstanding balance. The applicable Installment Amount may be paid in cash or in shares of the Company’s Common Stock (a “Company Conversion”). In the event of a Company Conversion the number of shares of Common Stock due to Tonaquint will be based on a conversion price that is equal to the lower of i) the Conversion Price and ii) 70% of the three (3) lowest closing volume-weighted average prices (“VWAPs”) of the Company’s Common Stock for a period of twenty (20) trading days, provided, however, that if the arithmetic average of the three (3) lowest VWAPs of the shares of Common Stock during any twenty (20) consecutive trading day period is less than $0.01, then the conversion described above will be based on 65% of the VWAPs.

13

Part I, Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The information in this quarterly report on Form 10-Q contains forward-looking statements.  These forward-looking statements involve risks and uncertainties, including statements regarding our capital needs, business strategy and expectations.  Any statements contained in this report that are not statements of historical facts may be deemed to be forward-looking statements.  In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential” or “continue”, the negative of such terms or other comparable terminology.  Actual events or results may differ materially from those events or results included in the forward-looking statements.  In evaluating these statements, you should consider various factors, including the risks outlined from time to time in the reports we file with the Securities and Exchange Commission.  Some, but not all, of these risks include, among other things:

● our inability to obtain the financing we need to continue our operations;

● changes in regulatory requirements that adversely affect our business;

● loss of our key personnel; and

● risks over which we have no control, such as the general global downturn in the economy which may adversely affect spending by private and government agencies.

We do not intend to update forward-looking statements.  You should refer to and carefully review the information in future documents we file with the Securities and Exchange Commission.

Overview and Plan of Operation

The water treatment recycling and reuse industry is highly fragmented, consisting of many companies involved in various operational capacities, including companies that design fully integrated systems for processing millions of gallons of water for municipal, industrial, and commercial applications. Demand for water treatment and purification has continued to grow due to economic expansion, population growth, scarcity of usable water, concerns about water quality and regulatory requirements.

Many believe the world is facing a global crisis in both the supply and quality of available water. Water is a natural resource that has a limited supply and no true substitute with only a small percentage of the earth’s water is available for human consumption. Demand for water resources is compounded by a growing and developing world population, Third World urbanization, and increasing water usage in industries such as oil and gas, agriculture and food processing. It has been reported in a television broadcast by CNBC titled “Liquid Assets: The Big Business of Water,” aired originally in 2010, that by 2025, 48 countries will be without sufficient water to meet basic requirements. We believe the lack of water resources is directly linked to inadequate water management strategies on the part of governments, businesses, consumers and private individuals. We believe that the demand for cost-effective water treatment technology and services will continue to grow.

We plan to continue marketing our existing patented Sionix Dissolved Air Flotation (“DAF”) system to potential domestic and international customers. We believe that we are now able to aggressively market our systems to a variety of private companies and governmental entities in several vertical markets including oil and gas, agriculture, manufacturing, health care and public water utilities. We are engaging in selective sales and promotional activities in connection with the operation of the unit, including media exposure. If the unit continues to operate successfully, we believe we can receive orders for operating units.

We plan to market Sionix technology incorporating the patented Sionix DAF system to markets including; oil and gas drilling and production, agriculture, manufacturing, food processing, municipalities and public utilities.  We are also continuing to extend the Sionix technologies, add to the Company’s intellectual property and develop alliances and working relationships with independent laboratories, equipment manufacturers, technology providers and potential customers and partner in our markets of interest.

Recent Developments

The Company designed and manufactured a DAF system for a leading maple syrup producer in New York State.  The unit was leased to Madava Sugar Maple LLC and was operated between January and March 2013.  Sionix provided on-site training, installation, technical and research support during the sap-to-syrup production season.  The unit performed successfully, improving operating economics and product quality.  Sionix is engaged in discussions with the customer regarding upgrades to and sale of the unit, as well as announcing the results of the successful operation.  We anticipate that published results of this successful DAF performance will lead to further opportunities in this market.

14

The Company completed an initial demonstration of its proprietary water treatment technology in the Williston Basin of North Dakota in January 2013.  The processing facility located in Dickinson, North Dakota, successfully treated production and flow back water from drilling and fracking operations in the Bakken Shale.  The first round of testing was done with the participation of Clear Water Services, an independent, experienced and innovative water treating company and laboratory analysis was performed by two independent third party testing laboratories in North Dakota and California.  Test results show significant reduction in turbidity and total suspended solids as well as reductions in metals, hydrocarbons and bicarbonate.

In April 2013, Sionix began a second round of field testing after modifying equipment and its testing protocol based on information and analysis gleaned from earlier test results.  The treatment process consisted of initial residence time, pH control and chemical pre-treatment, clarification, filtration and the patented Sionix DAF system.  The objective of the test was to demonstrate the ability to treat commercial volumes of production and flow back water and generate treated brine that could be recycled for use in fracking.  Preliminary data from the second round of testing indicate the successful treatment of production and flow back waters that were destined for disposal wells.  Our process yielded clear, treated brine with a density of more than 9.6 pounds per gallon at a near neutral pH.

The Company plans to complete the analysis of test results and aggressively market the Sionix frack water recycling technology in the Bakken and other shale areas as a cost-effective way to treat flow back and production water and return it to the driller for reuse in fracking.

Results of Operations

Three Months Ended March 31, 2013, Compared to Three Months Ended March 31, 2012

Revenues for the three months ended March 31, 2013 and 2012 were $27,500 and $0, respectively.

The Company’s total operating expenses were $1,660,455 during the three months ended March 31, 2013, an increase of $834,883 or 101%, as compared to $825,572 for the three months ended March 31, 2012.  General and administrative expenses were $790,506 during the three months ended March 31, 2013, an increase of $203,339 or 35%, as compared to $587,167 for the three months ended March 31, 2012.  The net increase in general and administrative expenses was the result of severance costs incurred. Sales and marketing expenses were $6,096 for the three months ended March 31, 2013, a decrease of $56,786 or 90%, as compared to $62,881 for the three months ended March 31, 2012. The decrease in sales and marketing expense was related to a reduction of personnel and vendors for sales support and the related payroll taxes and benefits, as well as decreased travel and related expenses. Research and development expenses were $856,544 during the three months ended March 31, 2013, an increase of $684,963 or 399%, as compared to $171,581 for the three months ended March 31, 2012.  This increase is directly attributable to the write off and the write down of inventory due to obsolescence, lack of the ability to realize the carrying value of the inventory and the change in the product mix required by the change in business focus and the costs associated with ongoing tests in the Williston Basin.

The Company also incurred interest costs related to various notes in the amount of $204,480 during the three months ended March 31, 2013, a decrease of $39,251 or 16% as compared to $243,731 for the six months ended March 31, 2012. Normal operations were limited by the lack of available cash.  The Company also incurred a loss on the change in the fair value of the derivative liability of $4,185,376 during the three months ended March 31, 2013, an increase of $4,183,678 as compared to a loss of $1,698 for the three months ended March 31, 2012.

Six Months Ended March 31, 2013 Compared to Six Months Ended March 31, 2012

Revenues for the six months ended March 31, 2012 and 2011 were $27,500 and $0, respectively.

The Company’s total operating expenses were $2,501,948 during the six months ended March 31, 2013, an increase of $658,531 or 36%, as compared to $1,843,416 for the six months ended March 31, 2012.  General and administrative expenses were $1,293,370 during the six months ended March 31, 2013, a decrease of $79,418 or 6%, as compared to $1,372,788 for the six months ended March 31, 2012.  Sales and marketing expenses were $53,812 for the six months ended March 31, 2013, a decrease of $94,495 or 64%, as compared to $148,307 for the six months ended March 31, 2012.  The decrease in sales and marketing expense was related to a loss of personnel and vendors for sales support, as well as decreased travel and related expenses. Research and development expenses were $1,137,389 during the six months ended March 31, 2013, an increase of $822,515 or 261%, as compared to $314,873 for the six months ended March 31, 2012. This increase is directly attributable to the write off and the write down of inventory due to obsolescence, lack of the ability to realize the carrying value of the inventory and the change in the product mix required by the change in business focus and the costs associated with ongoing tests in the Williston Basin.

The Company also incurred interest costs related to various notes in the amount of $500,890 during the six months ended March 31, 2013, an increase of $38,625 or 8%, as compared to $462,625 for the six months ended March 31, 2012. Normal operations were limited by the lack of available cash. The Company also incurred a loss on the change in the fair value of the derivative liability of $4,107,185 during the six months ended March 31, 2013, an increase of $4,105,812 as compared to a loss of $1,373 for the six months ended March 31, 2012.

15

Liquidity and Capital Resources

The Company had cash of $27,235 and $1,348,069 at March 31, 2013 and September 30, 2012, respectively.  Historically the Company’s source of cash for operations has been the sale of its equity and debt securities. During the period ended March 31, 2013 the Company obtained $275,000 from the sale of notes. If it does not receive additional orders or if these orders do not satisfy its capital needs, the Company expects to sell its securities or obtain loans to meet its capital requirements.  The Company has no additional orders for the sale of water treatment systems or for the deployment of its DAF system, except as noted above.  There can be no assurance that sales of the Company’s securities, additional contracts for the sale of water treatment services, or of its water treatment systems, if such sales occur, will provide sufficient capital for its operations or that the Company will not encounter unforeseen difficulties that may deplete its capital resources more rapidly than anticipated.  As of March 31, 2013, approximately $3,407,711 in principal and interest of certain promissory notes issued by the Company were due or will be coming due on or before September 30, 2014, which is the latest maturity date of its existing notes.  The Company can continue normal operations for approximately one month unless additional financing is obtained.

Operating Activities

During the six months ended March 31, 2013, the Company used $1,451,802 of cash in operating activities, primarily to fund its net loss. Non-cash adjustments included $215,078 for common stock and notes issued for services, $4,107,185 for a loss on the change in derivative liability and $412,405 for the amortization of debt discounts. Cash provided by operating activities included $418,653 in accrued expenses. Cash used in operating activities included $52,506 in other current assets.

Investing Activities

During the six months ended March 31, 2013, the Company received net proceeds from the sale of property and equipment totaling $5,748, as compared to acquisitions of $41,192 during the six months ended March 31, 2012.

Financing Activities

Financing activities by the Company provided net cash of $95,546 and $2,342,700 during the six months ended March 31, 2013 and March 31, 2012, respectively.

As of March 31, 2012, the Company had an accumulated deficit of $44,476,875. Management anticipates that future operating results will continue to be subject to many of the problems, expenses, delays and risks inherent in the establishment of a developmental business enterprise, many of which the Company cannot control.

16

Material Trends, Events or Uncertainties

The Company is not certain how the current economic downturn may affect its business.  Because of the global recession, government agencies and private industry may not have the funds to purchase its water treatment systems.  It may also be more difficult for the Company to raise capital in the current economic environment. Other than as discussed herein, the Company does not know of any material trends, events or uncertainties that may impact its operations in the future.

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of the Company’s assets and the satisfaction of its liabilities in the normal course of business. Through March 31, 2013, the Company has incurred cumulative losses of $44,476,875 including a net loss for the three months ended March 31, 2013 of $5,858,967. As the Company has no cash flow from operations, its ability to maintain normal operations is entirely dependent upon obtaining adequate cash to finance its overhead, research and development activities, and acquisition of production equipment. It is unknown when, if ever, the Company will achieve a level of revenues adequate to support its costs and expenses. In order for the Company to meet its basic financial obligations, including rent, salaries, debt service and operations, it plans to seek additional equity or debt financing. Because of the Company’s history and current debt levels, there is considerable doubt that the Company will be able to obtain financing. The Company’s ability to meet its cash requirements for the next twelve months depends on its ability to obtain such financing. Even if financing is obtained, any such financing will likely involve additional fees and debt service requirements that may significantly reduce the amount of cash it will have for operations. Accordingly, there is no assurance that the Company will be able to implement its plans.

The Company expects to continue to incur substantial operating losses for the foreseeable future, and it cannot predict the extent of the future losses or when it may become profitable, if ever. The Company expects to incur increasing sales and marketing, research and development and general and administrative expenses. Also, the Company has a substantial amount of short-term debt, which will need to be repaid or refinanced, unless it is converted into equity. As a result, if the Company begins to generate revenues from operations, those revenues will need to be significant in order to cover current and anticipated expenses. These factors raise substantial doubt about the Company's ability to continue as a going concern unless it is able to obtain substantial additional financing in the short term and generate revenues over the long term. If the Company is unable to obtain financing, it would likely discontinue its operations.

Critical Accounting Policies

The discussion and analysis of its financial condition and results of operations is based upon the Company’s unaudited condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires it to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an on-going basis, the Company evaluates its critical accounting policies and estimates. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The Company’s critical accounting policies and estimates are discussed in its Annual Report on Form 10-K for the fiscal year ended September 30, 2012.

17

Part I, Item 3.  Quantitative and Qualitative Disclosures about Market Risk.

As a smaller reporting company, the Company is not required to provide this disclosure.

Part I, Item 4.  Controls and Procedures.

(a) Disclosure Controls and Procedures

Regulations under the Securities Exchange Act of 1934 require public companies to maintain “disclosure controls and procedures,” which are defined to mean a company’s controls and other procedures that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

We conducted an evaluation, with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the period covered by this report.  Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of March 31, 2012, our disclosure controls and procedures were effective.

(b) Changes in internal control over financial reporting

During the three months ended March 31, 2012, the Company has not made any changes to internal control over financial reporting that have materially affected, or are reasonably likely to affect, its internal control over financial reporting.

Part II, Item 1.  Legal Proceedings.

On April 2, 2013, Dean Delis brought suit against the Company, several current and former directors and executives, and Ascendiant Securities, LLC in the U.S. District Court for the Northern District of California.  The suit alleges various causes of action, including violations of federal and state securities laws, in connection with Mr. Delis’s 2012 purchase of a convertible debenture issued by the Company.  The Company denies the allegations and believes the suit lacks merit.  On April 29, 2013, the Company moved to dismiss the complaint.  The Company’s motion to dismiss is currently pending.  The Company does not believe the ultimate resolution of this matter will have a material adverse effect on its financial position. 

On October 24, 2012 our former Chairman and Chief Executive Officer, James. R. Currier filed in the Superior Court of the State of Arizona in and for the County of Maricopa a legal action against us entitled “James R. Currier v. Sionix Corporation, a Nevada corporation." Mr. Currier's complaint contained claims alleging Breach of Contract, Breach of Implied Covenant of Good Faith and Fair Dealing, Wage Claim, Negligent Misrepresentation and Fraud. The allegations in the complaint related to his resignation from his position as Chief Executive Officer, and from the board as its Chairman and as a member.  The parties have resolved Mr. Currier's claims.

Part II, Item 1A.  Risk Factors.

We incorporate herein by reference the information included in Item 1A. of the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on December 31, 2012.

Part II, Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

During the three months ended March 31, 2012, we:

●      Issued 34,224,930 shares of common stock for conversion of debt in the amount of $453,024 (including interest). We relied on Section 3(a)(9) of the Securities Act as providing an exemption from registering the issuance of these shares of common stock inasmuch as the conversion was made with our existing security holders exclusively and no commission or other remuneration was paid or given directly or indirectly for soliciting the exchange.

18

Part II, Item 3. Defaults Upon Senior Securities

None.

Part II, Item 4.  Mine Safety Disclosure.

Not required.

Part II, Item 5.  Other Information.

(a) None.

(b) There were no changes to the procedures by which security holders may recommend nominees to our board of directors.

Part II, Item 6.  Exhibits.

Exhibit No.	Description of Exhibit
3.1	Articles of Incorporation (1)
3.1.1	Amendment to Articles of Incorporation (2)
3.2	Bylaws (1)
31.1	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101.INS	XBRL INSTANCE DOCUMENT
101.SCH	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
101.CAL	XBRL TAXONOMY CALCULATION LINKBASE DOCUMENT
101.DEF	XBRL TAXONOMY DEFINITION LINKBASE DOCUMENT
101.LAB	XBRL TAXONOMY LABEL LINKBASE DOCUMENT
101.PRE	XBRL TAXONOMY PRESENTATION LINKBASE DOCUMENT

* Filed herewith.

(1) Incorporated by reference from our Current Report on Form 8-K filed with the Securities and Exchange Commission on July 15, 2003 as file number 002-95626-D.

(2) Incorporated by reference from Annex 1 to our definitive proxy statement filed with the Securities and Exchange Commission on February 7, 2010 as file number 002-95626-D.

19

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 21, 2013

SIONIX CORPORATION

/s/ Henry W. Sullivan

Henry W. Sullivan

Chief Executive Officer (Principal Executive Officer)

/s/ Joseph W. Autem

Joseph W. Autem

Chief Financial Officer, Secretary/Treasurer, and Principal Financial and Accounting Officer

20

EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

and Securities and Exchange Commission Release 34-46427

I, Henry W. Sullivan, certify that:

1. I have reviewed this report on Form 10-Q of Sionix Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 21, 2013 /s/ Henry W. Sullivan           Henry W. Sullivan Principal Executive Officer

EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

and Securities and Exchange Commission Release 34-46427

I, Joseph W. Autem, certify that:

1. I have reviewed this report on Form 10-Q of Sionix Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 21, 2013 /s/ Joseph W. Autem           Joseph W. Autem Principal Financial Officer

EX-32.1

Exhibit 32.1

Certification of Principal Executive Officer

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Sionix Corporation (the "Company") on Form 10-Q for the period ended March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Henry W. Sullivan, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Henry W. Sullivan          

Henry W. Sullivan

Principal Executive Officer

May 21, 2013

EX-32.2

Exhibit 32.2

Certification of Principal Financial Officer

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Sionix Corporation (the "Company") on Form 10-Q for the period ended March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Joseph W. Autem, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Joseph W. Autem           

Joseph W. Autem

Principal Financial Officer

May 21, 2013

XML

Stockholders' Equity (Details 3) (Stock Warrants [Member], USD $)	6 Months Ended
	Mar. 31, 2013
Schedule of options/warrants outstanding and exercisable
Options/Warrants Outstanding	110,011,903
Options/Warrants Exercisable	110,011,903
$ 0.06 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.06
Options/Warrants Outstanding	11,262,500
Options/Warrants Exercisable	11,262,500
Options/Warrants Contractual Life	3 years 4 months 16 days
Weighted Average Exercise Price Outstanding	$ 0.06
Weighted Average Exercise Price Exercisable	$ 0.06
$ 0.07 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.07
Options/Warrants Outstanding	22,833,333
Options/Warrants Exercisable	22,833,333
Options/Warrants Contractual Life	1 year 3 months 14 days
Weighted Average Exercise Price Outstanding	$ 0.07
Weighted Average Exercise Price Exercisable	$ 0.07
$ 0.08 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.08
Options/Warrants Outstanding	25,425,000
Options/Warrants Exercisable	25,425,000
Options/Warrants Contractual Life	4 years 8 months 22 days
Weighted Average Exercise Price Outstanding	$ 0.08
Weighted Average Exercise Price Exercisable	$ 0.08
$ 0.10 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.10
Options/Warrants Outstanding	6,726,578
Options/Warrants Exercisable	6,726,578
Options/Warrants Contractual Life	2 years
Weighted Average Exercise Price Outstanding	$ 0.10
Weighted Average Exercise Price Exercisable	$ 0.10
$ 0.12 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.12
Options/Warrants Outstanding	6,226,000
Options/Warrants Exercisable	6,226,000
Options/Warrants Contractual Life	8 months 8 days
Weighted Average Exercise Price Outstanding	$ 0.12
Weighted Average Exercise Price Exercisable	$ 0.12
$ 0.14 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.14
Options/Warrants Outstanding	5,000,000
Options/Warrants Exercisable	5,000,000
Options/Warrants Contractual Life	2 years 6 months 22 days
Weighted Average Exercise Price Outstanding	$ 0.14
Weighted Average Exercise Price Exercisable	$ 0.14
$ 0.15 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.15
Options/Warrants Outstanding	2,107,667
Options/Warrants Exercisable	2,107,667
Options/Warrants Contractual Life	1 year 6 months 29 days
Weighted Average Exercise Price Outstanding	$ 0.15
Weighted Average Exercise Price Exercisable	$ 0.15
$ 0.17 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.17
Options/Warrants Outstanding	24,230,825
Options/Warrants Exercisable	24,230,825
Options/Warrants Contractual Life	2 years 10 months 24 days
Weighted Average Exercise Price Outstanding	$ 0.17
Weighted Average Exercise Price Exercisable	$ 0.17
$ 0.25 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.25
Options/Warrants Outstanding	3,700,000
Options/Warrants Exercisable	3,700,000
Options/Warrants Contractual Life	1 year 2 months 12 days
Weighted Average Exercise Price Outstanding	$ 0.25
Weighted Average Exercise Price Exercisable	$ 0.25
$ 0.30 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.30
Options/Warrants Outstanding	2,500,000
Options/Warrants Exercisable	2,500,000
Options/Warrants Contractual Life	4 months 24 days
Weighted Average Exercise Price Outstanding	$ 0.30
Weighted Average Exercise Price Exercisable	$ 0.30

XML

Accrued Expenses (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2012
Accrued Expenses (Textual)
Debt conversion, accrued interest converted into stock	$ 13,032

XML

Accrued Expenses

6 Months Ended

Mar. 31, 2013

Accrued Expenses [Abstract]

Accrued Expenses

Note 4 – Accrued Expenses

Accrued expenses consisted of the following at:

	March 31, 2013		September 30, 2012
Accrued salaries	$	412,938	$	306,055
Interest payable		464,457		364,567
Other accrued expenses		417,073		237,106
Total accrued expenses	$	1,294,468	$	907,728

During the three months ended March 31, 2012, $13,032 of accrued interest was included in the conversion of notes payable into common stock described in Note 6.

XML

Long Term Debt (Details) (USD $)	6 Months Ended		0 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Nov. 26, 2012 10% Convertible Debt (WBI) [Member]
Long Tem Debt (Textual)
Description of consideration offered by company for repurchase of outstanding membership interest in WBI			Company offered the members the option of receiving a pro-rata share of the remaining capital invested into WBI, or they could assign their rights to their remaining capital to Sionix in return for a convertible note issued by Sionix equal to 100% of their original investment.
Amount of cash available for cash distribution			$ 854,046
Percentage of distribution on original investment			63.30%
Amount of original investment			1,350,000
Amount of original investment returned			569,649
Decreased amount of original investment			900,000
Convertible notes payable	2,231,849	1,983,358	450,000
Remaining capital of original investment			284,397
Additional capital received from issuance of additional notes			250,000
Amount of additional note issued			394,000
Debt discount			144,000
Convertible notes maturity date	Sep. 30, 2014		Sep. 30, 2014
Interest rate on convertible note			10.00%
Convertible notes conversion price			$ 0.04
Payment of placement agent fees			$ 45,000

XML

12% Secured Promissory Note (Details) (USD $)	6 Months Ended			0 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Nov. 08, 2011 12% Secured Promissory Note [Member]
12% Secured Promissory Note (Textual)
Interest rate on secured promissory note				12.00%
Secured promissory notes	$ 64,027	$ 64,027	$ 64,027	$ 300,000
Maturity date of secured promissory note	Sep. 30, 2014			Jul. 31, 2012
Debt instrument percentage of redemption premium				7.50%
Stock issued during the period as incentive shares				2,358,491
Stock issued during the period as pledged shares				16,981,132
Redemption amount of incentive shares				$ 125,000

XML

Stockholders' Equity (Details) (Employee Stock Options and Warrants [Member], USD $)	6 Months Ended	12 Months Ended
	Mar. 31, 2013	Sep. 30, 2012
Employee Stock Options and Warrants [Member]
Summary of the Company's activity for employee stock options/ stock warrants
Outstanding options/warrant, Beginning balance	43,716,316
Granted option	500,000
Expired option	(3,933,526)
Forfeited option	(500,000)
Exercised option
Outstanding options/warrants, Ending balance	39,782,790	43,716,316
Outstanding options/warrants exercisable	39,779,665
Outstanding options, Weighted Average Exercise Price, Beginning balance	$ 0.12
Granted, Weighted Average Exercise Price	$ 0.15
Expired, Weighted Average Exercise Price	$ 0.21
Forfeited, Weighted Average Exercise Price	$ 0.15
Exercised, Weighted Average Exercise Price
Outstanding options/warrants, Weighted Average Exercise Price, Ending balance	$ 0.11	$ 0.12
Outstanding options/warrants exercisable, Weighted Average Exercise Price	$ 0.11
Outstanding options/warrants, Aggregate Intrinsic Value
Outstanding options/warrants, Granted, Aggregate Intrinsic Value
Outstanding options/warrants, Expired, Aggregate Intrinsic Value
Outstanding options/warrants, Forfeited , Aggregate Intrinsic Value
Outstanding options/warrants, Exercised, Aggregate Intrinsic Value
Outstanding options/warrants, Aggregate Intrinsic Value
Outstanding options/warrants exercisable, Aggregate Intrinsic Value
Outstanding options, Weighted Average Remaining Contractual Life	1 year 11 months 23 days	3 years 4 days
Outstanding Options Granted, Weighted Average Remaining Contractual Life	4 years 9 months
Outstanding options exercisable, Weighted Average Remaining Contractual Life	1 year 11 months 23 days

XML

Stockholders' Equity (Details 1) (Employee Stock Options and Warrants [Member], USD $)	6 Months Ended
	Mar. 31, 2013
Schedule of options/warrants outstanding and exercisable
Options/Warrants Outstanding	39,782,790
Options/Warrants Contractual Life	1 year 11 months 23 days
Options/Warrants Exercisable	39,779,665
Weighted Average Remaining Contractual Life	1 year 11 months 23 days
$ 0.06 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.06
Options/Warrants Outstanding	7,415,000
Options/Warrants Contractual Life	2 years 8 months 5 days
Options/Warrants Exercisable	7,411,875
Weighted Average Remaining Contractual Life	2 years 8 months 5 days
$ 0.07 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.07
Options/Warrants Outstanding	2,000,000
Options/Warrants Contractual Life	2 years 9 months
Options/Warrants Exercisable	2,000,000
Weighted Average Remaining Contractual Life	2 years 9 months
$ 0.09 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.09
Options/Warrants Outstanding	2,000,000
Options/Warrants Contractual Life	2 years 9 months
Options/Warrants Exercisable	2,000,000
Weighted Average Remaining Contractual Life	2 years 9 months
$ 0.10 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.10
Options/Warrants Outstanding	8,416,850
Options/Warrants Contractual Life	1 year 6 months 4 days
Options/Warrants Exercisable	8,416,850
Weighted Average Remaining Contractual Life	1 year 6 months 4 days
$ 0.12 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.12
Options/Warrants Outstanding	8,450,940
Options/Warrants Contractual Life	1 year 0 months 11 days
Options/Warrants Exercisable	8,450,940
Weighted Average Remaining Contractual Life	1 year 0 months 11 days
$ 0.14 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.14
Options/Warrants Outstanding	500,000
Options/Warrants Contractual Life	3 years 2 months 1 day
Options/Warrants Exercisable	500,000
Weighted Average Remaining Contractual Life	3 years 2 months 1 day
$ 0.15 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.15
Options/Warrants Outstanding	11,000,000
Options/Warrants Contractual Life	2 years 1 month 28 days
Options/Warrants Exercisable	11,000,000
Weighted Average Remaining Contractual Life	2 years 1 month 28 days

XML

Property and Equipment

6 Months Ended

Mar. 31, 2013

Property and Equipment [Abstract]

Property and Equipment

Note 3 – Property and Equipment

Property and equipment consisted of the following at:

	March 31, 2013			September 30, 2012
Machinery and equipment	$	109,336		$	166,159
Less accumulated depreciation		(38,544	)		(38,040	)
Property and equipment, net	$	70,792		$	128,119

Depreciation expense for the three months ended March 31, 2013 and 2012 was $7,309 and $3,942, respectively. For the six months ended March 31, 2013 and 2012, depreciation expense was $17,377 and $7,448, respectively.

XML

Stockholders' Equity (Details 2) (Stock Warrants [Member], USD $)	6 Months Ended
	Mar. 31, 2013
Stock Warrants [Member]
Summary of the Company's activity for employee stock options/ stock warrants
Outstanding options/warrant, Beginning balance	114,460,085
Granted warrants	625,000
Expired warrants	(4,223,182)
Forfeited warrants
Exercised warrants
Outstanding options/warrants, Ending balance	110,011,903
Outstanding options/warrants exercisable	110,011,903
Outstanding options, Weighted Average Exercise Price, Beginning balance	$ 0.12
Granted, Weighted Average Exercise Price
Expired, Weighted Average Exercise Price	$ 0.18
Forfeited, Weighted Average Exercise Price
Exercised, Weighted Average Exercise Price
Outstanding options/warrants, Weighted Average Exercise Price, Ending balance	$ 0.11
Outstanding options/warrants exercisable, Weighted Average Exercise Price	$ 0.11
Outstanding options/warrants, Aggregate Intrinsic Value	$ 75,000
Outstanding options/warrants, Granted, Aggregate Intrinsic Value
Outstanding options/warrants, Expired, Aggregate Intrinsic Value
Outstanding options/warrants, Forfeited , Aggregate Intrinsic Value
Outstanding options/warrants, Exercised, Aggregate Intrinsic Value
Outstanding options/warrants, Aggregate Intrinsic Value	75,000
Outstanding options/warrants exercisable, Aggregate Intrinsic Value	$ 75,000

XML

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2013	Sep. 30, 2012
Current assets:
Cash and cash equivalents	$ 27,235	$ 1,348,069
Other receivable	12,500	27,854
Inventory	790,000	1,311,349
Other current assets	116,423	91,529
Total current assets	946,158	2,778,801
Non-current assets:
Property and equipment, net	70,792	128,119
Total assets	1,016,950	2,906,920
Current liabilities:
Accounts payable	263,306	155,547
Accrued expenses	1,294,468	907,728
Notes payable - related parties	45,000	25,000
Convertible notes, net of debt discount	2,005,146	1,895,378
Secured promissory notes	64,027	64,027
Deferred Revenue	10,000	10,000
Derivative liability	4,478,105	638,178
Shares to be issued		165,880
Total current liabilities	8,160,052	3,628,699
Long-Term Debt, net of discount	793,355
Total Liabilities	8,953,407	4,023,392
Stockholders' Deficit Attributable to Sionix Corporation:
Preferred stock, $0.001 par value, 10,000,000 shares authorized at March 31, 2013
Common stock, $0.001 par value (600,000,000 shares authorized; 451,246,460 shares issued and outstanding at March 31, 2013; 387,968,434 shares issued and outstanding at September 30, 2012)	451,246	387,968
Additional paid-in capital	36,089,172	34,807,672
Accumulated deficit	(44,476,875)	(37,560,000)
Total stockholders' deficit attributable to Sionix Corporation	(7,936,457)	(2,364,360)
Equity attributable to noncontrolling interest		1,247,888
Total stockholders' deficit	(7,936,457)	(1,116,472)
Total liabilities and stockholders' deficit	$ 1,016,950	$ 2,906,920

XML

Organization and Description of Business

6 Months Ended

Mar. 31, 2013

Organization and Description Of Business [Abstract]

Organization and Description of Business

Note 1 – Organization and Description of Business

Sionix Corporation (the "Company") was incorporated in Utah in 1996.  The Company completed its reincorporation as a Nevada corporation effective July 1, 2003. Sionix designs, develops, markets and sells cost-effective water management and treatment solutions intended for use in the oil and gas, agriculture, food processing, industrial, disaster relief, and municipal (both potable and wastewater) markets  The Company’s water treatment systems include filtration, pretreatment, pH control, clarification, ultra violet, reverse osmosis and feature the patented Sionix Dissolved Air Flotation (“DAF”) technology.  The proprietary DAF system incorporates unique design elements including a distribution of fine, small diameter air bubbles that remove most solid particles, hydrocarbons and dissolved gases from the influent.  The micro-bubbles capture contaminants and float them to the surface of the DAF tank where they are skimmed off.

XML

Going Concern (Details) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012	Sep. 30, 2012
Going Concern (Textual)
Accumulated deficit	$ (44,476,875)		$ (44,476,875)		$ (37,560,000)
Net loss	$ (5,858,967)	$ (1,309,805)	$ (6,916,876)	$ (2,504,307)

XML

Property and Equipment (Details) (USD $)	Mar. 31, 2013	Sep. 30, 2012
Components of property and equipment
Machinery and equipment	$ 109,336	$ 166,159
Less accumulated depreciation	(38,544)	(38,040)
Property and equipment, net	$ 70,792	$ 128,119

XML

Subsequent Events (Details) (USD $)	6 Months Ended					0 Months Ended		1 Months Ended
	Mar. 31, 2013	Mar. 31, 2013 Subsequent Event [Member] Additional 10% Convertible Debentures [Member]	Mar. 31, 2013 Subsequent Event [Member] Additional 10% Convertible Debentures [Member] Minimum [Member]	Mar. 31, 2013 Subsequent Event [Member] Additional 10% Convertible Debentures [Member] Maximum [Member]	Mar. 31, 2013 Subsequent Event [Member] Additional 6% Convertible Redeemable Note [Member]	Apr. 11, 2013 Subsequent Event [Member] JMJ Financial Convertible Promissory Note [Member]	Apr. 19, 2013 Subsequent Event [Member] JMJ Financial Convertible Promissory Note [Member]	Apr. 19, 2013 Subsequent Event [Member] Tonaquint Convertible Promissory Note [Member]
Subsequent Events (Textual)
Convertible notes maturity date	Sep. 30, 2014	Dec. 31, 2014				Apr. 11, 2014		Aug. 19, 2014
Interest rate on convertible redeemable note		10.00%			6.00%			8.00%
Convertible promissory note, principal amount		$ 150,000			$ 50,000	$ 75,000	$ 155,000
Debt issue discount						10.00%		10.00%
Convertible debt, terms of conversion		The notes are convertible at any time at the option of the holders into shares of our common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request.				At a conversion price equal to 60% of the three (3) lowest closing price of the Company's common stock for a period of twenty (20) trading days, but no lower than $0.03 per share.
Right of redemption, description						The Company has an optional right of redemption at any time before ninety (90) days from the JMJ Effective Date, after which prepayment may not be made without prior approval from the lender and a one-time interest charge of 12% will be applied to the JMJ Principal Amount.
One time debt redemption charges						12.00%
Additional debt provided by lender						175,000
Liquidated damage charges on debt principal amount						25.00%
Minimum amount of liquidated damage charges						25,000
Expiration period of warrant issued along with convertible promissory note	5 years							5 years
value of stock issuable upon exercise of warrant								62,000
Convertible notes conversion price			$ 0.02	$ 0.04
Convertible notes, share issuable upon conversion		7,000,000
Warrant exercise price								$ 0.06
Fees paid by company								$ 5,000
Debt prepayment notice period								5 days
Debt Prepayment Description								Minimum 135% of the amount of the Tonaquint Principal Amount.
Debt interest rate upon an event of default								18.00%
Stock and Warrant Conversion Price								$ 0.03
Payment period of convertible instrument								Beginning on a date that is 180 days after the date of issuance of the Tonaquint Note.
Convertible instrument, payment terms								The Company shall pay, on a monthly basis, the greater of (i) $15,500, plus the sum of any accrued and unpaid interest as of the applicable installment date and accrued, and unpaid late charges, if any, under the Tonaquint Note as of the applicable installment date, and any other amounts accruing or owing to Tonaquint and (ii) the then outstanding balance of the Tonaquint Note divided by the number of installment dates remaining prior to the Maturity Date.
Common Stock Conversion Price, Description								Conversion price that is equal to the lower of i) the Conversion Price and ii) 70% of the three (3) lowest closing volume-weighted average prices ("VWAPs") of the Company's Common Stock for a period of twenty (20) trading days, provided, however, that if the arithmetic average of the three (3) lowest VWAPs of the shares of Common Stock during any twenty (20) consecutive trading day period is less than $0.01, then the conversion described above will be based on 65% of the VWAPs.

XML

Accrued Expenses (Details) (USD $)	Mar. 31, 2013	Sep. 30, 2012
Components of accrued expenses
Accrued salaries	$ 412,938	$ 306,055
Interest payable	464,457	364,567
Other accrued expenses	417,073	237,106
Total accrued expenses	$ 1,294,468	$ 907,728

XML

Basis of Presentation and Summary of Significant Accounting Policies

6 Months Ended

Mar. 31, 2013

Basis Of Presentation and Summary Of Significant Accounting Policies [Abstract]

Basis of Presentation and Summary of Significant Accounting Policies

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies

In the opinion of management, the accompanying balance sheets and related interim statements of operations, and cash flows include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s annual report on Form 10-K for the fiscal year ended September 30, 2012 filed with the U.S. Securities and Exchange Commission (the “Commission”) on December 31, 2012.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  Significant estimates include collectability of accounts receivable, accounts payable, sales returns, and recoverability of long-term assets.

Consolidation

All significant intercompany accounts and balances have been eliminated in consolidation. Participation of other unit holders in the net assets and net earnings of consolidated subsidiaries is included in the captions ‘equity attributable to noncontrolling interest’ and ‘net loss attributable to the noncontrolling interest’ in the accompanying condensed consolidated balance sheet and condensed consolidated statement of operations, respectively.

Recently Issued Accounting Pronouncements

In December 2011, the FASB issued disclosure guidance related to the offsetting of assets and liabilities. The guidance requires an entity to disclose information about offsetting and related arrangements for recognized financial and derivative instruments to enable users of its financial statements to understand the effect of those arrangements on its financial position. The amended guidance is effective for us on a retrospective basis commencing in the first quarter of 2014. We are currently evaluating the impact of this new guidance on our consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, “Intangibles – Goodwill and Other (Topic 350): Testing Goodwill for Impairment.” ASU No. 2011-08 provides companies an option to perform a qualitative assessment to determine whether further goodwill impairment testing is necessary. If, as a result of the qualitative assessment, it is determined that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, the two-step quantitative impairment test is required. Otherwise, no further testing is required. ASU No. 2011-08 will be effective for the Company for goodwill impairment tests performed in the fiscal year ending September 30, 2013, with early adoption permitted. The adoption of this guidance is expected to have no impact on the Company’s consolidated financial condition and results of operations.

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220): Presentation of Comprehensive Income.” ASU No. 2011-05 eliminates the option to present components of other comprehensive income as part of the statement of shareholders’ equity. All non-owner changes in shareholders’ equity instead must be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Also, reclassification adjustments for items that are reclassified from other comprehensive income to net income must be presented on the face of the financial statements. ASU No. 2011-05 was effective for the Company for the quarter ending December 31, 2012. The adoption of this guidance had no impact on the Company’s financial condition and results of operations.

In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs.” ASU No. 2011-04 clarifies and changes the application of various fair value measurement principles and disclosure requirements, and was effective for the Company in the second quarter of fiscal 2012 (January 1, 2012). The adoption of this guidance had no impact on the Company’s consolidated financial condition and results of operations.

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)	Mar. 31, 2013	Sep. 30, 2012
Balance Sheets [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	600,000,000	600,000,000
Common stock, shares issued	451,246,460	387,968,434
Common stock, shares outstanding	451,246,460	387,968,434

XML

Subsequent Events

6 Months Ended

Mar. 31, 2013

Subsequent Events [Abstract]

Subsequent Events

Note 12 – Subsequent Events

Additional 10% Convertible Debentures:

Subsequent to the period ended March 31, 2013 the Company received additional funding of $150,000 in principal amount of 10% Convertible Promissory Notes which have not yet been converted into shares of our common stock.  The notes are convertible at any time at the option of the holders into shares of our common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request, however the conversion price may not exceed $0.04, and may not be lower than $0.02 per share.  Based on the outstanding principal amount of these notes and assuming that interest accrued through December 31, 2014, the due date, the notes would be convertible into approximately 7,000,000 shares of our common stock at a conversion price of $0.02 a share.

Additional 6% Convertible Redeemable Note:

Subsequent to the period ended March 31, 2013 the Company received an advance of $50,000 in principal amount based on the 6% Convertible Redeemable Note agreement.

JMJ Financial Convertible Promissory Note

On April 11, 2013 (the “JMJ Effective Date”), the Company issued a Convertible Promissory Note to JMJ Financial (the “JMJ Note”) in the principal amount of $75,000 (the “JMJ Principal Amount”), including a 10% original issue discount, at a conversion price equal to 60% of the three (3) lowest closing price of the Company’s common stock for a period of twenty (20) trading days, but no lower than $0.03 per share.  The JMJ Note matures on April 11, 2014. The Company has an optional right of redemption at any time before ninety (90) days from the JMJ Effective Date, after which prepayment may not be made without prior approval from the lender and a one-time interest charge of 12% will be applied to the JMJ Principal Amount. The JMJ Note also provides for up to an additional $175,000 to be provided to the Company at the lender’s sole discretion.

The shares underlying conversion of the JMJ Note have piggyback registration rights and if the Company fails to register such shares in its next registration statement filed with the SEC a liquidated damage charge of 25% of the outstanding principal balance, but not less than $25,000, shall be added to such outstanding balance.

Tonaquint Convertible Promissory Note

On April 19, 2013, pursuant to the terms and conditions of that certain securities purchase agreement, by and between the Company and Tonaquint, Inc. (“Tonaquint), the Company issued to Tonaquint: i) a convertible promissory note (the “Tonaquint Note”) in the principal amount of $155,000 (the “Tonaquint Principal Amount”), including a 10% original issue discount, maturing on August 19, 2014 (the “Maturity Date”) and ii) a five (5) year warrant (the “Tonaquint Warrant”) to purchase that number of shares of the Company’s Common Stock equal to $62,000, convertible at a conversion price as set forth in the Tonaquint Note and exercisable at $0.06 per share, as adjusted pursuant to the terms and conditions of the Tonaquint Warrant. The Company paid fees of $5,000 incurred by Tonaquint in connection with the funding of this loan. The Company has the optional right to prepay any portion of the Tonaquint Principal Amount upon providing Tonaquint with five (5) days’ notice of such prepayment, provided that the Company must pay Tonaquint 135% of the amount of the Tonaquint Principal Amount it elects to prepay. Interest on the Tonaquint Note shall accrue at 8% per annum, provided that upon an Event of Default (as defined in the Tonaquint Note) the interest rate shall increase to 18%.

The conversion price for each share of Common Stock issuable pursuant to the Tonaquint Note and the Tonaquint Warrant will be $0.03 (the “Conversion Price”), subject to adjustments as set forth in the Tonaquint Note and the Tonaquint Warrant; provided, however, that, beginning on a date that is 180 days after the date of issuance of the Tonaquint Note, the Company shall pay, on a monthly basis, the greater of (i) $15,500, plus the sum of any accrued and unpaid interest as of the applicable installment date and accrued, and unpaid late charges, if any, under the Tonaquint Note as of the applicable installment date, and any other amounts accruing or owing to Tonaquint and (ii) the then outstanding balance of the Tonaquint Note divided by the number of installment dates remaining prior to the Maturity Date (each, an “Installment Amount’). Notwithstanding any other provision of the Tonaquint Note, if any Installment Amount is greater than the then outstanding balance of the Tonaquint Note, such Installment Amount shall be reduced to equal such then outstanding balance. The applicable Installment Amount may be paid in cash or in shares of the Company’s Common Stock (a “Company Conversion”). In the event of a Company Conversion the number of shares of Common Stock due to Tonaquint will be based on a conversion price that is equal to the lower of i) the Conversion Price and ii) 70% of the three (3) lowest closing volume-weighted average prices (“VWAPs”) of the Company’s Common Stock for a period of twenty (20) trading days, provided, however, that if the arithmetic average of the three (3) lowest VWAPs of the shares of Common Stock during any twenty (20) consecutive trading day period is less than $0.01, then the conversion described above will be based on 65% of the VWAPs.

XML

Document and Entity Information	6 Months Ended
	Mar. 31, 2013	May 01, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	SIONIX CORP
Entity Central Index Key	0000764667
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Document Type	10-Q
Document Period End Date	Mar. 31, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q2
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		454,866,623

XML

Basis of Presentation and Summary of Significant Accounting Policies (Policies)

6 Months Ended

Mar. 31, 2013

Basis Of Presentation and Summary Of Significant Accounting Policies [Abstract]

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  Significant estimates include collectability of accounts receivable, accounts payable, sales returns, and recoverability of long-term assets.

Consolidation

Consolidation

All significant intercompany accounts and balances have been eliminated in consolidation. Participation of other unit holders in the net assets and net earnings of consolidated subsidiaries is included in the captions ‘equity attributable to noncontrolling interest’ and ‘net loss attributable to the noncontrolling interest’ in the accompanying condensed consolidated balance sheet and condensed consolidated statement of operations, respectively.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

In December 2011, the FASB issued disclosure guidance related to the offsetting of assets and liabilities. The guidance requires an entity to disclose information about offsetting and related arrangements for recognized financial and derivative instruments to enable users of its financial statements to understand the effect of those arrangements on its financial position. The amended guidance is effective for us on a retrospective basis commencing in the first quarter of 2014. We are currently evaluating the impact of this new guidance on our consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, “Intangibles – Goodwill and Other (Topic 350): Testing Goodwill for Impairment.” ASU No. 2011-08 provides companies an option to perform a qualitative assessment to determine whether further goodwill impairment testing is necessary. If, as a result of the qualitative assessment, it is determined that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, the two-step quantitative impairment test is required. Otherwise, no further testing is required. ASU No. 2011-08 will be effective for the Company for goodwill impairment tests performed in the fiscal year ending September 30, 2013, with early adoption permitted. The adoption of this guidance is expected to have no impact on the Company’s consolidated financial condition and results of operations.

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220): Presentation of Comprehensive Income.” ASU No. 2011-05 eliminates the option to present components of other comprehensive income as part of the statement of shareholders’ equity. All non-owner changes in shareholders’ equity instead must be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Also, reclassification adjustments for items that are reclassified from other comprehensive income to net income must be presented on the face of the financial statements. ASU No. 2011-05 was effective for the Company for the quarter ending December 31, 2012. The adoption of this guidance had no impact on the Company’s financial condition and results of operations.

In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs.” ASU No. 2011-04 clarifies and changes the application of various fair value measurement principles and disclosure requirements, and was effective for the Company in the second quarter of fiscal 2012 (January 1, 2012). The adoption of this guidance had no impact on the Company’s consolidated financial condition and results of operations.

XML

Condensed Consolidated Statement of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Statement Of Operations [Abstract]
Net Revenue	$ 27,500		$ 27,500
Cost of revenues	4,558		4,558
Gross profit	22,942		22,942
Operating expenses
General and administrative	790,506	587,167	1,293,370	1,372,788
Sales and marketing	6,096	62,882	53,812	148,307
Research and development	856,544	171,581	1,137,388	314,873
Depreciation	7,309	3,942	17,377	7,448
Total operating expenses	1,660,455	825,572	2,501,948	1,843,416
Loss from operations	(1,637,513)	(825,572)	(2,479,006)	(1,843,416)
Other income (expense)
Interest expense and financing costs	(204,480)	(243,731)	(500,890)	(462,625)
Loss on change in fair value of derivative liability	(4,185,376)	(1,698)	(4,107,185)	(1,373)
Other income	(2,301)		(4,528)
Legal settlements
Gain (Loss) on settlement of debt	170,703	(238,804)	174,734	(196,893)
Total other income (expense)	(4,221,545)	(484,233)	(4,437,870)	(660,891)
Loss before income taxes	(5,858,967)	(1,309,805)	(6,916,876)	(2,504,307)
Income taxes
Net loss	(5,858,967)	(1,309,805)	(6,916,876)	(2,504,307)
Less: Net loss attributable to the noncontrolling interest		2,587		2,587
Net loss attributable to Sionix Corporation	$ (5,858,967)	$ (13,072,180)	$ (6,916,876)	$ (2,501,720)
Amounts attributable to Sionix Corporation:
Basic loss per share	$ (0.01)	$ 0.00	$ (0.02)	$ (0.01)
Diluted loss per share	$ (0.01)	$ 0.00	$ (0.02)	$ (0.01)
Basic weighted average number of shares of common stock outstanding	440,415,881	324,493,782	419,966,351	314,627,551
Diluted weighted average number of shares of common stock outstanding	440,415,881	324,493,782	419,966,351	314,627,551

XML

12% Secured Promissory Note

6 Months Ended

Mar. 31, 2013

Convertible Notes, 12 Secured Promissory Note and Long Term Debt [Abstract]

12% Secured Promissory Note

Note 7 – 12% Secured Promissory Note

On November 8, 2011 Sionix issued a 12% Secured Promissory Note in the principal amount of $300,000 maturing on July 31, 2012. The Company had an optional right of redemption prior to maturity. Sionix was to redeem the debenture on the maturity date at a redemption premium of 7.5%. Sionix granted to the investor a continuing, first priority security interest in certain property of Sionix to secure the prompt payment, performance, and discharge in full of all of the Company’s obligations under the Secured Promissory Note, Securities Purchase Agreement, and Pledge Agreement.

In connection with this borrowing, Sionix issued 2,358,491 shares of common stock as Incentive Shares, and 16,981,132 shares of common stock as Pledged Shares. At the Company’s option, the Incentive Shares may be redeemed for cash in the amount of $125,000; otherwise they are retained by the lender. The value of the Incentive Shares has been classified as a liability and is being amortized as interest expense over the term of the borrowing. The Pledged Shares were issued as security under the Pledge Agreement.

The Company is continuing to issue shares to reduce the outstanding balance, and no default based on the elapsed maturity date has been declared by the note holder.  After conversions, the amount outstanding as of December 31, 2012 amounted to $64,027.

XML

Convertible Notes

6 Months Ended

Mar. 31, 2013

Convertible Notes, 12 Secured Promissory Note and Long Term Debt [Abstract]

Convertible Notes

Note 6 – Convertible Notes

At March 31, 2013 and December 31, 2012, convertible notes payable amounted to $2,231,849 and $1,983,358, respectively, net of discounts of $202,789 and $355,680 respectively. The notes bear interest at 6% - 12% per annum, and are convertible into common stock of the Company at $0.02 - $0.15 per share (as well as variable conversion rates as described below). The notes are due at various dates through September 2014 and are unsecured.

Unsecured Convertible Notes:

Through December 31, 2012, the Company issued $700,000 of convertible debentures (of which $87,500 is outstanding at December 31, 2012) that are convertible into common stock of the Company at variable conversion rates that provide a fixed rate of return to the note-holder. Under the terms of the notes, however, the Company could be required to issue additional shares of common stock in the event of default. The Company applied the provisions of ASC Topic 815, “Derivatives and Hedging” and determined that the conversion option should be bifurcated from the notes and valued separately. This conversion option has been recorded as a derivative liability, is being amortized over the terms of the related notes, and is carried at fair value in the accompanying balance sheet. During the three months ended December 31, 2012 and 2011, the change in fair value of this derivative liability amounted to $78,191 and $325, respectively.

During the three months ended December 31, 2012, holders of convertible debentures elected to convert $82,500 of their debt plus accrued interest into 8,569,317 shares of common stock.

6% Convertible Redeemable Note:

On November 23, 2011 Sionix issued a 6% Convertible Redeemable Note in the principal amount $100,000 maturing on November 23, 2012. In addition, the Company received a commitment in the form of a promissory note from the lender pursuant to which the lender provided the Company with funding of up to an additional $300,000 beginning on June 1, 2012, at which time $100,000 became available, on each of June 1, 2012, July 1, 2012 and August 1, 2012 (the "Additional Financing"). All funds were advanced as agreed for a total of $400,000. Sionix paid fees of $45,000 in connection with the funding of these loans. The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.

For the period ending December 31, 2012 there was $36,600 outstanding on these Notes.

On September 21, 2012 Sionix issued a 6% Convertible Redeemable Note in the principal amount $100,000 to GEL Properties.  The note matures on September 21, 2013.  The Company has an optional right of redemption prior to maturity upon a five-day notice and payment of a 50% premium on the unpaid principal amount of the loan.  The Company paid fees of $6,000 in connection with the funding of this loan. In addition, the Company received a commitment in the form of a promissory note from GEL Properties pursuant to which it will provide Sionix with funding of an additional $300,000, $100,000 of which will become available on each of July 1, 2013, August 15, 2013 and October 1, 2013.  The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.

For the period ending December 31, 2012 there was $100,000 outstanding on these Notes.

10% Convertible Debentures:

On September 29, 2012 the Company entered into a securities purchase agreement dated September 25, 2012 with several accredited investors (“Holders”) for the purchase and sale of $1,025,000 of its convertible notes (“Notes”) and warrants.    The Notes bear interest at the rate of 10% per annum beginning as of September 25, 2012, and mature on June 25, 2013.  On the closing date, the Company paid and the Holders received nine months of pre-paid interest on the original principal amount of the Notes (based on the agreed nine-month term of the Notes).

The Notes are convertible at any time at the option of the Holders into the Company’s common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request, however the conversion price may not exceed $0.04, and may not be lower than $0.02 per share.  The Notes may be redeemed by the Company at any time prior to maturity with ten days’ prior notice to the Holders, and payment of a premium of 25% on the unpaid principal amount of the Notes.  In addition the Notes and related securities purchase agreement contain representations, warranties and covenants that are customary for financings of this type.

The Company issued warrants to the Holders for the purchase of up to 23,125,000 shares of Company common stock, pro rata in proportion to the amount invested, which can be exercised for a period of five years from the closing date, with a fixed exercise price of $0.08 per share.

The Company agreed to register the common stock into which the Notes may be converted, any shares of common stock that may be issued as payment of principal or interest, and the common stock underlying the warrants, as well as any shares of common stock that may be issued as a result of any stock split, dividend or other distribution. The Company agreed to file an initial registration statement within 30 days of the date of the registration rights agreement.  If the Company fails to file a registration statement within this 30 day period, or to have it declared effective within 90 days after the date of the registration rights agreement, or to maintain its effectiveness (in addition to other events described in the full text of the registration rights agreement), the Company will be obligated to pay the investors liquidated damages equal to 2% of the principal amount of the Notes per month until the event is cured, for up to one year, and 1% per month thereafter if the event continues uncured

The offering was made with the services of a placement agent.  At the closing of the sale and issuance of the Notes, the Company paid a cash fee to the placement agent in the amount of $87,535 or 8.54% of the gross proceeds of the offering.

January Convertible Notes:

On January 25, 2013 the Company entered into securities purchase agreements (the “January SPAs”) with two (2) accredited investors (the “January Holders”) for the purchase and sale of $140,000 of convertible notes (the “January 2013 Notes”) convertible into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a conversion price equal to 80% of the average of the three (3) lowest closing prices for the Common Stock during the ten (10) consecutive trading days immediately preceding the conversion request, however the conversion price may not exceed $0.04 and may not be lower than $0.02 per share.   The January 2013 Notes bear interest at the rate of 10% per annum and mature on September 30, 2014.  The January 2013 Notes are convertible at any time at the option of the January Holders (subject to an increase in the Company’s authorized Common Stock, or a reverse split of its existing outstanding Common Stock with no change to its authorized Common Stock).  The Company may redeem the January 2013 Notes at any time prior to maturity with twenty (20) days’ prior notice to the January Holders and payment of a premium of 20% on the unpaid principal amount. 

In addition, the January 2013 Notes and January SPAs provide the January Holders with registration rights for the shares of Common Stock underlying the January 2013 Notes. If the Company fails to file a registration statement with the SEC covering such shares within thirty (30) days from the date of the January Notes, the Company shall pay to the January Holders an amount in cash, as partial liquidated damages, equal to 2% of the aggregate purchase price paid by the January Holders pursuant to the January SPAs until the first anniversary of the issue date and 1% of the same per month thereafter, not to exceed 10% of the principal amount in the aggregate.

March Convertible Notes:

On March 13, 2013 the Company entered into securities purchase agreements  (the “March SPAs”) with five (5) accredited investors (the “March Holders”) for the purchase and sale of $60,000 of convertible notes (the “March 2013 Notes”) convertible into shares of the Company’s Common Stock at a fixed conversion price of $0.02 per share.   The March 2013 Notes bear interest at the rate of 10% per annum and mature on September 30, 2014.  The March 2013 Notes are convertible at any time at the option of the March Holders (subject to an increase in the Company’s authorized Common Stock, or a reverse split of its existing outstanding Common Stock with no change to its authorized Common Stock).  The Company may redeem the March 2013 Notes at any time prior to maturity with twenty (20) days’ prior notice to the March Holders and payment of a premium of 20% on the unpaid principal amount.

XML

Property and Equipment (Details Textual) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Property and Equipment (Textual)
Depreciation expense	$ 7,309	$ 3,942	$ 17,377	$ 7,448

XML

Property and Equipment (Tables)

6 Months Ended

Mar. 31, 2013

Property and Equipment [Abstract]

Components of property and equipment

	March 31, 2013			September 30, 2012
Machinery and equipment	$	109,336		$	166,159
Less accumulated depreciation		(38,544	)		(38,040	)
Property and equipment, net	$	70,792		$	128,119

XML

Stockholders' Equity

6 Months Ended

Mar. 31, 2013

Stockholders' Equity [Abstract]

Stockholders' Equity

Note 10 – Stockholders’ Equity

Common Stock

The Company has 600,000,000 authorized shares of common stock, par value $0.001 per share. As of March 31, 2013, the Company had 451,246,460 shares issued and outstanding. As of September 30, 2012, the Company had 387,968,434 shares of common stock issued and outstanding.

During the six months ended March 31, 2013, the Company issued 7,314,379 shares of common stock for services to officers, directors and consultants (valued at $215,078) based on closing market prices. The Company also issued 40,220,361 shares of common stock for conversion of debt in the amount of $712,837 (including interest).

Employee Stock Options and Warrants

Stock Options

A summary of the Company’s activity for employee stock options and warrants:

	Number of Options			Weighted  Average  Exercise Price		Aggregate Intrinsic Value		Weighted  Average  Remaining  Contractual Life
Outstanding at October 1, 2012		43,716,316		$	0.12	$	-		3.01
Granted		500,000			0.15		-		4.75
Expired		(3,933,526	)		0.21		-		-
Forfeited		(500,000	)		0.15		-		-
Exercised		-			-		-		-
Outstanding at March 31, 2013		39,782,790			0.11		-		1.98
Exercisable at March 31, 2013		39,779,665		$	0.11	$	-		1.98

Outstanding and exercisable as of March 31, 2013:

	Exercise Price	Options Outstanding		Contractual Life		Weighted Average Remaining Options Exercisable		Weighted Average Remaining Contractual Life
$	0.06		7,415,000		2.44		7,411,875		2.44
$	0.07		2,000,000		2.75		2,000,000		2.75
$	0.09		2,000,000		2.75		2,000,000		2.75
$	0.10		8,416,850		1.51		8,416,850		1.51
$	0.12		8,450,940		1.03		8,450,940		1.03
$	0.14		500,000		3.17		500,000		3.17
$	0.15		11,000,000		2.16		11,000,000		2.16
			39,782,790		1.98		39,779,665		1.98

During the six months ended March 31, 2013, the Company granted a total of 500,000 options and warrants to certain officers and employees. The options and warrants vested immediately upon grant and have a term of five years. The weighted average grant-date fair value of these options and warrants was $14,671.  The fair value of these options and warrants was estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

● risk free rate of return of 0.72%;

● volatility of 171%

● dividend yield of 0%; and

● expected term of 5 years.

Stock Warrants

A summary of the Company’s warrant activity with non-employees:

	Number of Warrants			Weighted  Average  Exercise Price		Aggregate Intrinsic Value
Outstanding at October 1, 2012		114,460,085		$	0.12	$	75,000
Granted		625,000			-		-
Expired		(4,223,182	)		0.18		-
Forfeited		-			-		-
Exercised		-			-		-
Outstanding as of March 31, 2013		110,011,903		$	0.11	$	75,000
Exercisable as of March 31, 2013		110,011,903		$	0.11	$	75,000

Warrants outstanding and exercisable as of March 31, 2013:

						Weighted
						Average
						Remaining		Weighted Average
	Exercise	Warrants		Warrants		Contractual		Exercise Price
	Price	Outstanding		Exercisable		Life		Outstanding		Exercisable
$	0.06		11,262,500		11,262,500		3.17	$	0.06	$	0.06
$	0.07		22,833,333		22,833,333		1.04	$	0.07	$	0.07
$	0.08		25,425,000		25,425,000		4.12	$	0.08	$	0.08
$	0.10		6,726,578		6,726,578		2	$	0.10	$	0.10
$	0.12		6,226,000		6,226,000		.69	$	0.12	$	0.12
$	0.14		5,000,000		5,000,000		2.56	$	0.14	$	0.14
$	0.15		2,107,667		2,107,667		1.58	$	0.15	$	0.15
$	0.17		24,230,825		24,230,825		2.61	$	0.17	$	0.17
$	0.25		3,700,000		3,700,000		.82	$	0.25	$	0.25
$	0.30		2,500,000		2,500,000		.33	$	0.30	$	0.30
			110,011,903		110,011,903

Warrants expiring within twelve months of March 31, 2013 total 28,531,856.

XML

Long Term Debt

6 Months Ended

Mar. 31, 2013

Convertible Notes, 12 Secured Promissory Note and Long Term Debt [Abstract]

Long Term Debt

Note 8 – Long Term Debt

10% Convertible Debt (WBI):

On November 26, 2012 Sionix completed the repurchase of all outstanding membership interests in WBI.  In return for their membership interests and the release of WBI from any future claims, the Company offered the members the option of receiving a pro-rata share of the remaining capital invested into WBI, or they could assign their rights to their remaining capital to Sionix in return for a convertible note issued by Sionix equal to 100% of their original investment. The pro-rata share calculation did not include Sionix's interest in WBI. The cash available for distribution totaled $854,046 or 63.3% of the original investment of $1,350,000. The Company returned $569,649 of the original capital invested, representing an original investment of $900,000.

The Company issued convertible notes in the amount of $450,000 and received $284,397 of the remaining capital.  In addition, the Company received $250,000 of new capital in return for the issuance of an additional note of $394,000, and recognized a debt discount of $144,000 in connection with this new note.

The convertible notes issued mature on September 30, 2014, bear an annual interest rate of 10% payable in cash or in kind at our election, and are convertible at the election of the holder into common shares of Sionix at a rate of $0.04.

As part of this offering, the Company paid a placement agent a fee of $45,000 for services rendered in connection with this transaction.

XML

Income Taxes

6 Months Ended

Mar. 31, 2013

Income Taxes [Abstract]

Income Taxes

Note 9 – Income Taxes

For the six months ended March 31, 2013, the accompanying Condensed Consolidated Statements of Operations reflect net income that is largely comprised of items that do not represent taxable income.

XML

Going Concern

6 Months Ended

Mar. 31, 2013

Going Concern [Abstract]

Going Concern

Note 11 – Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of the Company’s assets and the satisfaction of its liabilities in the normal course of business. Through March 31, 2013, the Company has incurred cumulative losses of $44,476,875, including a net loss for the six months ended March 31, 2012 of $6,916,876. As the Company has limited cash flow from operations, its ability to maintain normal operations is entirely dependent upon obtaining adequate cash to finance its overhead, research and development activities, and acquisition of production equipment. It is unknown when, if ever, the Company will achieve a level of revenues adequate to support its costs and expenses. In order for the Company to meet its basic financial obligations, including salaries, debt service and normal operating expenses, it plans to sell additional units of its water treatment systems, and to seek additional equity or debt financing. Because of the Company’s history and current debt levels, there is considerable doubt that the Company will be able to obtain financing. The Company’s ability to meet its cash requirements for the next twelve months depends on its ability to obtain such financing. Even if financing is obtained, any such financing will likely involve additional fees and debt service requirements which may significantly reduce the amount of cash we will have for our operations. Accordingly, there is no assurance that the Company will be able to implement its plans.

As mentioned in Notes 5, 6, 7 and 8, the Company has related party notes, convertible notes, and subordinated debentures that have matured. The Company is continuing its efforts to obtain customers for its products expand its sales efforts worldwide and expand the industries it targets for possible customers. The Company also has future plans for additional products, and revisions to its current products. In support of this the Company plans to hire additional personnel who have the industry experience and the training so that they can be immediately effective in the building of the Company. The Company has dedicated significant resources to apply its technology to the treatment of both production and flow back water from oil and gas fracking operations.  Field and laboratory tests were conducted in the Bakken Shale area of North Dakota and the Company will continue to develop commercial opportunities to treat both production and flow back water for reuse in fracking as a strategic market objective.  The Company is also continuing to seek additional investment capital in the form of debt or equity to continue operations, and is considering certain changes to its capital structure to become more attractive to potential investors and business partners.

XML

Stockholders' Equity (Details Textual) (USD $)	6 Months Ended
	Mar. 31, 2013	Sep. 30, 2012
Stockholders' Deficit (Textual)
Warrant expiration period	5 years
Common stock, shares authorized	600,000,000	600,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	451,246,460	387,968,434
Common stock, shares outstanding	451,246,460	387,968,434
Common stock issued for services, shares	7,314,379
Common stock issued for services	$ 215,078
Number of shares of common stock issued for conversion of debt	40,220,361
Value of shares of common stock issued for conversion of debt including interest	712,837
Options and warrants granted to officers and employees	500,000
Number of warrants expire in period	28,531,856
Weighted average grant-date fair value of options and warrants	$ 14,671
Employee Stock Options and Warrants [Member]
Stockholders' Deficit (Textual)
Risk free rate of return	0.72%
Volatility	171.00%
Dividend yield	0.00%
Expected term	5 years
Warrant [Member]
Stockholders' Deficit (Textual)
Warrant expiration period	20 months

XML

Stockholders' Equity (Tables)

6 Months Ended

Mar. 31, 2013

Employee Stock Options and Warrants [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of the Company's activity for employee stock options/ stock warrants

	Number of Options			Weighted  Average  Exercise Price		Aggregate Intrinsic Value		Weighted  Average  Remaining  Contractual Life
Outstanding at October 1, 2012		43,716,316		$	0.12	$	-		3.01
Granted		500,000			0.15		-		4.75
Expired		(3,933,526	)		0.21		-		-
Forfeited		(500,000	)		0.15		-		-
Exercised		-			-		-		-
Outstanding at March 31, 2013		39,782,790			0.11		-		1.98
Exercisable at March 31, 2013		39,779,665		$	0.11	$	-		1.98

Schedule of options/warrants outstanding and exercisable

	Exercise Price	Options Outstanding		Contractual Life		Weighted Average Remaining Options Exercisable		Weighted Average Remaining Contractual Life
$	0.06		7,415,000		2.44		7,411,875		2.44
$	0.07		2,000,000		2.75		2,000,000		2.75
$	0.09		2,000,000		2.75		2,000,000		2.75
$	0.10		8,416,850		1.51		8,416,850		1.51
$	0.12		8,450,940		1.03		8,450,940		1.03
$	0.14		500,000		3.17		500,000		3.17
$	0.15		11,000,000		2.16		11,000,000		2.16
			39,782,790		1.98		39,779,665		1.98

Stock Warrants [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of the Company's activity for employee stock options/ stock warrants

	Number of Warrants			Weighted  Average  Exercise Price		Aggregate Intrinsic Value
Outstanding at October 1, 2012		114,460,085		$	0.12	$	75,000
Granted		625,000			-		-
Expired		(4,223,182	)		0.18		-
Forfeited		-			-		-
Exercised		-			-		-
Outstanding as of March 31, 2013		110,011,903		$	0.11	$	75,000
Exercisable as of March 31, 2013		110,011,903		$	0.11	$	75,000

Schedule of options/warrants outstanding and exercisable

						Weighted
						Average
						Remaining		Weighted Average
	Exercise	Warrants		Warrants		Contractual		Exercise Price
	Price	Outstanding		Exercisable		Life		Outstanding		Exercisable
$	0.06		11,262,500		11,262,500		3.17	$	0.06	$	0.06
$	0.07		22,833,333		22,833,333		1.04	$	0.07	$	0.07
$	0.08		25,425,000		25,425,000		4.12	$	0.08	$	0.08
$	0.10		6,726,578		6,726,578		2	$	0.10	$	0.10
$	0.12		6,226,000		6,226,000		.69	$	0.12	$	0.12
$	0.14		5,000,000		5,000,000		2.56	$	0.14	$	0.14
$	0.15		2,107,667		2,107,667		1.58	$	0.15	$	0.15
$	0.17		24,230,825		24,230,825		2.61	$	0.17	$	0.17
$	0.25		3,700,000		3,700,000		.82	$	0.25	$	0.25
$	0.30		2,500,000		2,500,000		.33	$	0.30	$	0.30
			110,011,903		110,011,903

XML

Notes Payable - Related Parties (Details) (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Dec. 31, 2012	Sep. 30, 2012
Notes Payable - Related Parties (Textual)
Maximum interest rate of notes	10.00%
Notes payable - related parties	$ 45,000		$ 25,000	$ 25,000
Accrued interest on notes	21,081		20,356
Interest expense	$ 725	$ 639

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities
Net loss	$ (6,916,876)	$ (2,504,307)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation	17,377	7,448
Amortization of debt discounts	412,405	222,569
Share based payments	14,671	139,420
Common stock issued for services	215,078	729,551
Loss on change in fair value of derivative liability	4,107,185	1,373
Gain on liquidation of subsidiary
Loss on sale of property and equipment	4,528
(Gain) loss on settlement of debt	(174,734)	196,893
Changes in operating assets and liabilities:
Inventory	521,349	(48,279)
Other current assets	(91,618)	(212,255)
Accounts payable	20,178	(10,696)
Accrued expenses	418,653	415,052
Deferred revenue
Net cash used by operating activities	(1,451,802)	(1,063,231)
Cash flows from investing activities:
Proceeds from sale of property and equipment	5,748	(41,192)
Cash flows from financing activities:
Borrowings, net	665,193	592,500
Common stock issued for cash		400,200
Noncontrolling interests in subsidiary issued for cash	(569,647)	1,350,000
Net cash provided by financing activities	95,546	2,342,700
Net increase (decrease) in cash and cash equivalents	(1,320,834)	1,238,277
Cash and cash equivalents, beginning of period	1,348,069	685
Cash and cash equivalents, end of period	27,235	1,238,962
SUPPLEMENTARY CASH FLOW INFORMATION:
Income taxes paid		599
Interest paid
Common stock issued in redemption of subsidiary interests	$ 450,000

XML

Notes Payable - Related Parties

6 Months Ended

Mar. 31, 2013

Notes Payable - Related Parties [Abstract]

Notes Payable - Related Parties

Note 5 – Notes Payable – Related Parties

The Company has received advances in the form of unsecured promissory notes from stockholders. The original date of these advances was November 2009, March 2011, October 2011 and March 2013. These notes bear interest at rates up to 10% and are due on demand. As of March 31, 2013 and December 31, 2012, such notes payable amounted to $45,000 and $25,000, respectively. Accrued interest on the notes amounted to $21,081 and $20,356 at March 31, 2013 and December 31, 2012, respectively, and is included in accrued expenses. Interest expense on these notes for the three months ended March 31, 2013 and 2012 amounted to $725 and $639, respectively. No demand for payment has been made as of March 31, 2013.

XML

Convertible Notes (Details) (USD $)	3 Months Ended		6 Months Ended		1 Months Ended	0 Months Ended					0 Months Ended	6 Months Ended			6 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Mar. 31, 2013	Sep. 30, 2012	Jan. 25, 2013 January Convertible Notes [Member]	Mar. 13, 2013 March Convertible Notes [Member]	Sep. 21, 2012 6% Convertible Redeemable Note	Nov. 23, 2011 6% Convertible Redeemable Note	Dec. 31, 2012 6% Convertible Redeemable Note November 23, 2011 [Member]	Dec. 31, 2012 6% Convertible Redeemable Note September 21, 2012 [Member]	Sep. 29, 2012 10% Convertible Debentures	Mar. 31, 2013 Minimum [Member]	Jan. 25, 2013 Minimum [Member] January Convertible Notes [Member]	Sep. 29, 2012 Minimum [Member] 10% Convertible Debentures	Mar. 31, 2013 Maximum [Member]	Jan. 25, 2013 Maximum [Member] January Convertible Notes [Member]	Sep. 29, 2012 Maximum [Member] 10% Convertible Debentures
Convertible Notes (Textual)
Convertible notes payable	$ 1,983,358		$ 2,231,849					$ 400,000
Discount on convertible note payable	355,680		202,789
Interest rate on convertible note					10.00%	10.00%					10.00%	6.00%			12.00%
Per share price of conversion of debt into common stock												$ 0.02			$ 0.15
Interest rate on convertible redeemable note							6.00%	6.00%
Convertible debentures issued, amount	700,000
Unsecured convertible, carrying amount of equity component	87,500
Change in fair value of derivative liability	78,191	325
Conversion of notes payable into common stock	82,500
Conversion of notes payable into common stock, shares	8,569,317
Convertible redeemable note, face amount							100,000	100,000
Convertible notes maturity date			Sep. 30, 2014		Sep. 30, 2014	Sep. 30, 2014	Sep. 21, 2013	Nov. 23, 2012
Convertible instrument, maturity, start date											Sep. 25, 2012
Convertible instrument, maturity, end date											Jun. 25, 2013
Convertible notes, fee amount							6,000	45,000
Debt outstanding amount									36,600	100,000
Convertible redeemable note subject to redemption, settlement terms, description					The January 2013 Notes are convertible at any time at the option of the January Holders (subject to an increase in the Company's authorized Common Stock, or a reverse split of its existing outstanding Common Stock with no change to its authorized Common Stock). The Company may redeem the January 2013 Notes at any time prior to maturity with twenty (20) days' prior notice to the January Holders and payment of a premium of 20% on the unpaid principal amount.	The Company may redeem the March 2013 Notes at any time prior to maturity with twenty (20) days' prior notice to the March Holders and payment of a premium of 20% on the unpaid principal amount.	An optional right of redemption prior to maturity upon a five-day notice and payment of a 50% premium on the unpaid principal amount of the loan.				The Notes may be redeemed by the Company at any time prior to maturity with ten days' prior notice to the Holders, and payment of a premium of 25% on the unpaid principal amount of the Notes.
Convertible debt, convertible, terms of conversion feature					At a conversion price equal to 80% of the average of the three (3) lowest closing prices for the Common Stock during the ten (10) consecutive trading days immediately preceding the conversion request, however the conversion price may not exceed $0.04 and may not be lower than $0.02 per share.		The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.	The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.			The Notes are convertible at any time at the option of the Holders into the Company's common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request.
Maximum period to file registration statement											30 days
Description for obligations in failure of filling registration statement					If the Company fails to file a registration statement with the SEC covering such shares within thirty (30) days from the date of the January Notes, the Company shall pay to the January Holders an amount in cash, as partial liquidated damages, equal to 2% of the aggregate purchase price paid by the January Holders pursuant to the January SPAs until the first anniversary of the issue date and 1% of the same per month thereafter, not to exceed 10% of the principal amount in the aggregate.						If the Company fails to file a registration statement within this 30 day period, or to have it declared effective within 90 days after the date of the registration rights agreement, or to maintain its effectiveness (in addition to other events described in the full text of the registration rights agreement), the Company will be obligated to pay the investors liquidated damages equal to 2% of the principal amount of the Notes per month until the event is cured, for up to one year, and 1% per month thereafter if the event continues uncured.
Convertible notes, additional funding provided by lender to the company in the form of a promissory note							300,000	300,000
Description of convertible notes additional borrowing							Sionix with funding of an additional $300,000, $100,000 of which will become available on each of July 1, 2013, August 15, 2013 and October 1, 2013.	Company with funding of up to an additional $300,000 beginning on June 1, 2012, at which time $100,000 became available, on each of June 1, 2012, July 1, 2012 and August 1, 2012.
Convertible notes conversion price						$ 0.02							$ 0.02	$ 0.02		$ 0.04	$ 0.04
Sale of convertible debt to accredited investor					140,000	60,000					1,025,000
Common stock, par value			$ 0.001	$ 0.001	$ 0.001
Debt instrument maturity period											9 months
Number of shares to be purchased from issuance of warrants											23,125,000
Warrant vesting period											5 years
Warrants, exercise price											$ 0.08
Cash fee paid to the placement agent											$ 87,535
Percentage of gross proceeds of primary debentures paid as placement fee to agent											8.54%

XML

Accrued Expenses (Tables)

6 Months Ended

Mar. 31, 2013

Accrued Expenses [Abstract]

Components of accrued expenses

	March 31, 2013		September 30, 2012
Accrued salaries	$	412,938	$	306,055
Interest payable		464,457		364,567
Other accrued expenses		417,073		237,106
Total accrued expenses	$	1,294,468	$	907,728